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ABSTRACT
The impacts of using health-promoting Saccharomyces cerevisiae fermentation
metabolites in poultry production and processing can be measured in respect to multiple
measures of success. Traditionally this yeast-based compound has been administered to poultry,
livestock, poultry, and other species to improve animal performance and production volume
output. In addition, Saccharomyces cerevisiae fermentation metabolites have also been shown in
more recent research to reduce colonization of pathogenic bacteria in the host organism’s gastrointestinal tract. In this dissertation, the impacts of administering a functional ingredient
containing Saccharomyces cerevisiae metabolites on broiler performance measures and pathogen
reduction were measured. One of the studies in this research was conducted in controlled
environment research pens, in the absence of disease or stress. In this study, broiler feed
conversions and component parts yields were similar between the control and treated broilers.
As indicated by studies elsewhere, these results may have been different had the broilers been
exposed to a commercial setting, or disease challenges, or other stressors. Also, ceca and parts
that were provided by commercial plants that had processed broilers treated with a
Saccharomyces cerevisiae metabolite product had lower presence and quantities of Salmonella in
the ceca and component portions compared to samples obtained from non-treated broilers. In
addition, the ceca provided by commercial plants which had been exposed to the Saccharomyces
cerevisiae metabolite treatments had reduced Salmonella strength, with increased susceptibility
to selected antimicrobials. There are several practical applications of this research. The
metabolites of Saccharomyces cerevisiae fermentation may be considered in broiler and other
meat-animal production systems as one alternative in the multi-hurdle approach to reduce
pathogens. This technology may benefit some plants by reducing the need for in-plant

interventions, such as antimicrobial sprays and dips frequently used to achieve regulatory
standards. Researchers and integrators that choose to study the administration of the metabolites
of Saccharomyces cerevisiae fermentation to meat animals can gain valuable knowledge by
measuring the impacts on performance, yields, and pathogen presence in settings where the
technology has been applied over an extended period of time in a variety of experimental
conditions.
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CHAPTER I

INTRODUCTION
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INTRODUCTION
Poultry meat producers continually work to improve food safety for the benefits of their
consumers and in order to maintain company sustainability. In the meat and poultry production
industries, pathogen reduction has been an area of continual emphasis for many years, and there
are increasing needs to find alternative methods to reduce bacteria in muscle protein products.
While various species typically have a group of pathogenic bacteria that are commonly
associated with specific meat types, in poultry two pathogens commensal to the product that are
frequently of concern in poultry meat are Salmonella and Campylobacter. The Food and
Agriculture Organisation of the United Nations and the World Health Organisation [sic] has
stated that poultry meat has been associated frequently and consistently with the transmission of
enteric pathogens, including Salmonella and Campylobacter, and risk management strategies
have been offered (FAO/WHO, 2002, 2003). Furthermore, it has been demonstrated that these
pathogens on raw product are frequently transferred to utensils, equipment, and finished product;
for example, Campylobacter has been shown to transfer from raw chicken parts to cooked
chicken slices via cutting boards (Guyard-Nicodème et al., 2013). Therefore, poultry producers
and processors are constantly seeking to reduce these pathogens in order to reduce the risk of
foodborne illness.
Concurrently to the above challenges to reduce pathogens, poultry producers have the
additional challenges from consumers that have expressed a clear shift in opinions toward
removing antibiotics in animal agriculture. There have been various degrees of success with this
initiative, as some antibiotics have been effectively used under veterinarian prescriptions to
prevent and/or treat diseases. However, the public concern for creating antibiotic-resistant
pathogens has led many processors to seek alternatives to antibiotics. This has become so
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important to some consumers that standards have been developed by the United States
Department of Agriculture (USDA) for guidelines such as “Naturally Raised” livestock (USDA,
2009), and auditing has become a growing function within the Agricultural Marketing Service
(AMS) certification program in which participating companies have their processes audited for
strict antibiotic restriction and controls under a Process Verified Program (USDA AMS, 2018).
Another reason that alternative methods to reduce pathogens are being considered at an
increasing pace is that the USDA Food Safety Inspection Service (FSIS) periodically tightens
microbial standards to reduce pathogen loads on product. For example, in recent years FSIS has
implemented a new pathogen performance standard for various types of poultry products,
specifically for the pathogenic organisms Salmonella and Campylobacter (USDA FSIS, 2015).
These pathogen performance standards have been made more stringent over the years, as the
government attempts to achieve goals for reducing foodborne illness under its Healthy People
initiatives (USDHHS ODPHP, 2018). In order to achieve the goals of improving food safety
while meeting the requirements of regulators and consumers, poultry processing managers,
researchers, and regulators have focused on manufacturing plant multi-hurdle strategies while
using combinations of antimicrobial sprays, dips, and rinses to reduce pathogenic and spoilage
bacteria (Berrang and Bailey, 2009; Buncic and Sofos, 2012; Shackelford et al., 1993; USDA
FSIS, 2015). However, some consumers prefer to purchase products not treated with
antimicrobials to reduce bacteria, due to concerns about chemicals and their impact on consumer
health and/or product organoleptic characteristics. Therefore, while antimicrobial interventions
have been proven effective at reducing pathogens and bacterial loads, these interventions cannot
be used exclusively for all applications. Also, the antimicrobial interventions are most effective
when pathogen loads are minimal on incoming animals and raw materials, prior to processing.
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For these reasons, research projects to find inventive ways to reduce pathogens in live poultry
production are extensive. Research is very limited in determining how novel approaches to
pathogen reduction in live poultry production impact reductions of bacteria after product is
processed into component parts, packaged, and ready for sale to consumers.
The purpose of this dissertation research is to determine the effectiveness of feeding the
dried metabolites of Saccharomyces cerevisiae to broilers on bird performance, yields, and the
presence and quantity of Salmonella in broiler chickens as measured in the ceca and component
parts collected at the time of packaging for sale. Bird performance comparisons have been
made using a research pen trial setting of control, untreated birds with those fed Saccharomyces
cerevisiae metabolites, by measuring broiler feed conversion, weight gain, growth rate, and
component carcasses parts yields. Also, samples collected in multiple plants representing
integrated operations have been studied across multiple growing cycles to fully measure the
impact of feeding the dried metabolites of Saccharomyces cerevisiae yeast cultures to broiler
flocks on the Salmonella loads in ceca and parts after processing. A comparison of the impact of
Saccharomyces cerevisiae on cecal Salmonella virulence and susceptibility to selected antibiotics
was also conducted. This research dissertation was completed as an independent academic study
for the purpose of scientific research.
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CHAPTER II

REVIEW OF LITERATURE
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REVIEW OF LITERATURE

Common Microorganisms Associated with Poultry Production and Processing
There are numerous microbiological pathogens and spoilage organisms commensal to
poultry production. In order for poultry companies to implement effective strategies at reducing
bacteria using novel interventions such as Saccharomyces cerevisiae, understanding the
relationships between microorganisms in poultry and their impact on foodborne illness and/or
poultry meat quality and spoilage is relevant. Therefore, below is a brief review of some of the
most significant micro-organisms affecting broiler companies and chicken meat products.
Salmonella
Salmonellae are small, Gram-negative, non-sporing rods that are facultatively anaerobic.
These organisms are usually motile by peritrichous flagella, although non-motile strains are
known to exist. Salmonellae colonies are typically 2-4 mm in diameter, and well over 2,500
Salmonella serotypes have been isolated (Gast, 2007). The Salmonella subspecies names
frequently indicate the disease and the animal from which they were isolated, e.g. typhimurium,
gallinarium and enteritidis, or the name of the location where the strain was first isolated, e.g.
london and arizonae (Cowan, 1974). More recent classification schemes have been developed
based on somatic and flageller antigens (Jay, 1992).
Researchers consistently report that Salmonella is one of the most widespread pathogens
responsible for foodborne toxic infections in humans (Foley et al., 2008; Jay, 1992). The
pathogenesis of the organism has been reported to involve an enterotoxin and a cytotoxin.
Salmonella enterotoxin acts by elevating intestinal cyclic adenosine monophosphate (cAMP),
inducing fluid accumulation, pathogen accumulation, and toxicity (Peterson, 1980). In addition,
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intestinal mucosal cells are damaged by a cytotoxin, making these tissues more easily invaded
and damaged by the pathogen (Duebbert and Peterson, 1985). Although Salmonella organisms
generally disappear rapidly from the intestine, up to 5% of infected patients may become carriers
upon recovery (Jay, 1992). Cell proliferation in the magnitude of 107 – 109 is generally believed
necessary to cause salmonellosis, yet outbreaks have been measured at much lower quantities
(D’Aoust and Pivnick, 1976). A small number of serotypes are most associated with human and
animal diseases, such as, but not limited to, typhimurium, enteritidis, newport, heidelberg, and
montevideo (Foley and Lynne, 2008).
Researchers have described the Salmonella infection in poultry species to include
interaction of the infection with the immune system in three phases, which include pathogen
invasion of the gastrointestinal tract, establishment of a systemic infection to microphages and
dendritic cells that replicate in the spleen and liver, and finally a combination immune system
reactions such as pathogen clearance, establishment of a carrier state through adaptive response,
immunosuppression, or other responses (Chappell et al., 2009).
Campylobacter
The genus Campylobacter is a slender, spirally-curved rod possessing at least one polar
flagellum (Park et al., 1984), consisting of approximately 14 species, with Campylobacter jejuni
being one of the primary strains of importance in foods. It requires small amounts of oxygen (36%) for growth and carbon dioxide (approximately 10%) for substantive growth, is Gramnegative, oxidase and catalase positive, and will not grow in the presence of 3.5% NaCl or at
25oC. (Jay, 1992). The cells are very sensitive to freezing (Gill and Harris, 1984) and heat
(Blankenship and Craven, 1982). The interplay between this organism and other gastrointestinal
microbiota in broilers has been analyzed (Kaakoush et al., 2014), and remains an important
factor in determining ideal experimental design. Human stool samples taken in hospitals
7

nationwide have suggested that Campylobacter jejuni is a very significant common cause of
bacterial diarrhea (Blaser et al., 1982), causing enteritis through production of cytotoxins and
enterotoxins, some of which are heat-labile (Ruiz-Palacios et al., 1983), and are very invasive to
HeLa cells (Manninen et al., 1982). Campylobacter jejuni toxicity has been found to be
generally lower and more inconsistent in isolates found in chickens as compared to humans
(Gilbert and Slavik, 2004), although intestinal attachment and penetration abilities of the
organism have been found to be similar in either host (Gilbert and Slavik, 2005). Improvements
in hygiene of poultry processing equipment and water have reduced numbers of Campylobacter
on packaged poultry carcasses (Mead et al., 1995).
Escherichia coli
The USDA FSIS has deemed Escherichia coli as an indicator of choice for measuring
process controls for fecal contamination in slaughter facilities for poultry and other animals
(USDA FSIS, 1996). The enumeration of this organism has long been used as a process control
test important to sanitation and as an indicator of fecal contamination (Mehlman, 1984). The
National Research Council also stated that Escherichia coli was the best indicator of fecal
contamination among the commonly used fecal-indicator organisms (NRC, 1985). This bacteria
has strains that cause respiratory diseases, diarrhea, urinary tract infections, and other illnesses
(CDC, 2008). Broiler flocks with primary or secondary Escherichia coli infections may exhibit
airsacculitis (Carter and Chengappa, 1990). Poultry processing interventions such as countercurrent scalders, chlorinated rinses, carcasses washes, and reprocessing have been effective at
reducing this organism (Waldroup et al., 1992; Waldroup et al., 1993), and growth can be
controlled using specified refrigeration time and temperature regimes (Ingham et al., 2004).
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Other Microorganisms Associated with Poultry Production and Processing
In poultry production, the processing plant environment has been shown to be a source of
Listeria contamination in fresh and frozen chicken products (Lawrence and Gilmore, 1994;
Lawrence and Gilmore, 1995). Epidemiological studies have demonstrated that Listeria can
cause gastroenteritis in the absence of invasive disease; however, listeriosis in high-risk
individuals, such those that are pregnant, elderly, or immune-compromised, can lead to
significant health consequences (Ramaswamy et al., 2007). This organism has significant
growth and survival properties, including the ability to adhere to food contact surfaces, making
elimination from food processing quite complex (Earnshaw and Lawrence, 1998). Listeria
monocytogenes isolates have been isolated in poultry processing plants (Lawrence and Gilmore,
1995), and may persist in poultry processing due to development of biofilms and/or plasmidmediated resistance to commercial disinfectants (Earnshaw and Lawrence, 1998).
Clostridium perfringens is an important pathogen to both broiler producers and
processors, since it has a broad distribution, is part of the natural gut flora of warm blooded
animals, is capable of forming a spore for survival once exposed to oxygen, and is difficult to
eliminate (McCrea and Macklin, 2006). In one study of poultry chill water, Clostridium
perfringens was found to be a reliable indicator of fecal contamination of the water ecosystem
(Voidarou et al., 2007). Typical routes of this organism causing foodborne illness are from food
items such as gravies that are not properly cooled and stored after heating (Omaye, 2004).
Pseudomonas is a Gram-negative, aerobic rod (Kreig and Holt, 1984), and one of the
primary low-temperature spoilage organisms in poultry and food items (Jay, 1992), especially
under aerobic conditions imposed when oxygen permeable packaging materials are used (Kraft,
1992). As a psychrotrophic bacteria, it grows in refrigeration temperatures, but like many other
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aerobic bacteria, it is sensitive to carbon dioxide (Montville and Matthews, 2005). Some of the
most common off-odor producing bacteria isolated from spoiled broiler chicken carcasses have
been Pseudomonas fluorescens, Pseudomonas fragi, and Pseudomonas putida (Russell et al.,
1996). Quantification of Pseudomonas fluorescens can be used to predict the shelf life of fresh
chicken (Russell, 1997).
Shewanella putrefaciens is another spoilage organism associated with fresh poultry. This
Gram-negative, facultative anaerobe (Kreig and Holt, 1984) has been described as an an off-odor
producing bacteria isolated from spoiled broiler chicken carcasses (Russell et al., 1996). During
spoilage biochemical reactions and volitization, it releases methanol, hydrogen sulfides, and
trimethlyamines (Jay, 1992). Shewanella putrefaciens has been more resistant to chemical
sanitizers such as sodium hypochlorite than other spoilage bacteria such as the Pseudomonas
species (Russell, 1998).
Another common food spoilage organism associated with poultry is Acinetobacter. This
rod-shaped, Gram-negative aerobe (Kreig and Holt, 1984) has pyschrotrophic characteristics,
and is sensitive to carbon dioxide. Acinetobacter organisms can be well-managed by controlled
atmosphere packaging (Montville and Matthews, 2005). Besides contributing to food spoilage,
some species of Acinetobacter are also found in soil, water, and human skin, causing pneumonia
and blood or wound infections (CDC, 2004).
Even though there are many other bacteria species comprising the poultry microflora,
Salmonella species will be the emphasis of this dissertation from a microbiological perspective.
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Strategies Employed to Remove Pathogens and Spoilage Organisms in Poultry Production and
Processing
Poultry integrators and researchers have long recognized that the reduction of bacteria
requires a multi-hurdle approach across the wide spectrum of the vertically integrated poultry
industry. Thus, any study of one pathogen intervention must be considered with an
understanding of the other interventions employed that collectively serve to reduce
microorganisms. Therefore, following is a brief review of some common strategies used to
remove pathogens and spoilage organisms in poultry production and processing.
Breeding Stock and Hatchery Interventions
The production of commercial poultry originates with pedigree lines, which become the
great grandparents of broiler chickens. Unlike production ﬂocks, which are relatively shortlived, elite breeder ﬂocks may have a lifespan in excess of a year, so careful management is
necessary to prevent colonization by Salmonella and other pathogens (Cox and Pavic, 2010).
The control of Salmonella colonization is vital and stressed at the apex of production, as this
organism can be vertically transmitted from hen to egg (Liljebjelke et al., 2005). Breeder ﬂocks
are a primary area of emphasis in reducing pathogens such as Salmonella strains, because of the
likelihood that a colonized ﬂock may spread the bacterium to a large number of commercial
ﬂocks. When designing intervention strategies, the microbial ecology of the chicken is
understood in order to avoid unintended negative impacts of such technologies (Callaway et al.,
2008). Also, at the elite ﬂock levels, measures such as change-in–change-out of farm or shedbased apparel is commonly practiced, and in some countries shower-in–shower-out practices are
employed for using a thorough disinfection strategy prior-to and post-entry to breeder farms
(Lewerin et al., 2005).
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Eggs received from breeder farms are not necessarily pathogen free, and the external
debris or contamination can be transmitted to commercial hatchers and incubators.

Enteric

pathogens can then spread to other areas of the hatchery based on the design of facility airﬂow
(Bailey et al., 1998; Mitchell et al., 2002). Therefore, many methods are employed in
commercial hatcheries to control the spread of pathogens. Methods have included disinfecting
eggs with ultraviolet light, ozone, chemicals, electrostatic charging, pulsed light and gas plasma
(Coufal et al., 2003; Davies and Breslin, 2003; Dunn, 1996; Mitchell et al., 2002; RodriguezRomo and Yousef, 2005). Other egg disinfection methods have included the use of hydrogen
peroxide, quaternary ammonium compounds, peroxyacetic acid, and other compounds (Cox et
al. 2007). These egg disinfection procedures are often used within the hatchery; however, the
benefits of such egg disinfection technologies are frequently also effective if applied to freshly
laid eggs on the farm, prior to entering the hatchery environment (Cox and Pavic, 2010).
Broiler Microbial Interventions and Strategies
Researchers and commercial poultry operation managers have gone to extensive efforts
to reduce Salmonella and Campylobacter within vertically integrated broiler production process.
Effective cleaning and disinfection of broiler houses has been shown to have an immediate
impact of reduction of pathogens present in environmental sample as measured by reduced
Campylobacter jejuni immediately after cleaning (Burbarelli et al., 2017). Biosecurity measures
are used to prevent or reduce the spread of microorganisms in poultry houses through a set of
rules and procedures that minimize exposure of bird populations to infectious biological agents
(Cox, 2005; Wenzel and Nusbaum, 2007). Reducing the ingress of pathogen carriers including
wild birds, rats, insects, and humans is also an effective means of preventing or minimizing
enteric pathogens (Arsenault et al., 2007), including maintaining strict hygiene barrier areas for
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visitors and farm personnel to properly use designated boots and outer garments (Newell et al.,
2011). Broiler stock are typically populated and depopulated on an all-in, all-out basis to
minimize cross contamination between flocks that could otherwise occur with multi-stage
stocking (Plym-Forshell and Wierup, 2006). Numerous poultry house litter treatments have been
used to minimize enteric pathogens, including composting to reduce pathogens (Mohee et al.,
2008), or the use of granules that contain compounds such as sulfuric acid (Vicente et al., 2007),
sodium bisulfate (Line, 2002), or formic and propionic acid blends mixed with sodium
lignosulfate (Garrido, et al., 2004).
Microorganisms in feed may introduce pathogens such as Salmonella onto the farm
(Davies and Wales, 2010; Davies et al., 2004; Molla et al., 2010). The reduction of Salmonella
risk may be achieved in feed mills through milling controls such as heat treatment, and the
addition of organic acids and their salts and formaldehyde (Berge and Wierup, 2012). Coarseground grains and access to growing on litter vs. cages has also been shown to decrease cecal
Salmonella populations in broilers (Santos et al., 2008). The addition of pathogen interventions
to feeds has also been shown to potentially reduce organisms such as Salmonella in feed through
the inclusion of additives such as organic acids, selected fatty acids, prebiotics, probiotics,
competitive exclusion cultures, mannan-based carbohydrates, essential oils, and bacteriophages
(Berge and Wierup, 2012).
In poultry production systems, antibiotics have been used in many countries when
necessary to prevent, control, or treat bacterial infections, and improve bird health (Seiffert et al.,
2013). Some compounds that have reduced pathogens in poultry have included tetracyclines,
tylosin, lincomycin, flavomicin, and others. The carboxylic ionophore polyether anticoccidals
such as lasolocid, salinomycin, and naracin have also been shown effective at reducing
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Clostridium perfringens, necrotic enteritis, and other pathogens (Lanckriet et al., 2010; Martel et
al., 2004). However, antibiotic use in animal husbandry has become a topic of public concern
due to the potential of developing drug-resistant bacteria; for example, in some Latin-American
countries, increased rates of antimicrobial-resistant Campylobacter have been reported (Pollett et
al., 2012; Sierra-Arguello et al., 2016). This situation is of special relevance in developing
countries where the misuse of antibiotics and a lack of controls is a recognized challenge
(Reardon, 2014). Research trials with raising antibiotic-free chickens in tropical conditions with
conventional practices in the absence of other pathogen interventions was shown to cause
extensive hemorrhagic enteritis, typhlitis, Salmonella presence, and bird mortality (Ganapathy et
al., 2000). Therefore, alternative strategies to reduce pathogens in broilers with the absence of
antibiotics has been a focus area for poultry companies.
Processing Plant Interventions
In poultry plants, there are multiple sites where Salmonella can originate, be introduced
or subsequently spread through cross-contamination (Foley, et al., 2008). Therefore, multihurdle strategies have been employed in processing plants, and some of the most common plant
interventions are described below.
Initially, a bird brush and washer used prior to the scalder is frequently used to remove
incoming dirt and fecal material, to reduce the problem of excessive quantities of pathogens
entering the scalding system (USDA FSIS, 2015).

Picking machines specialized in the removal

of feathers using rotating rubber fingers to rub or beat the feathers off the carcass may cause
cross-contamination by enteric pathogens (Dickens and Whittemore, 1997), so picker fingers
consisting of certain rubber materials may be used to inhibit microbial contamination (Arnold
and Silvers, 2000). Studies using marker organisms and/or pulsed field gel electrophoresis have
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demonstrated that bacteria in live poultry can spread on poultry carcasses through the picking
process (Mulder et al., 1978; Nde et al., 2007). Therefore, carcass rinses applied during
defeathering may be used to decrease microbiological loads. For example, in a study that tested
water, acetic acid and hydrogen peroxide as sprays during defeathering, the combination of
sprays along with the massaging action of picker fingers on the carcass resulted in antimicrobial
effects, as chemicals were forced into the crevices of poultry skin where many bacteria are found
(Dickens and Whittemore, 1997).
Carcass washing and/or spraying is a common poultry processing step before, during, and
after evisceration. These technologies have shown to be effective in multiple locations in
reducing microbial contamination (Shackelford et al., 1993). Inside-outside bird washers have as
their primary function the removal of visible fecal material, and have shown to reduce coliforms,
Escherichia coli, and/or total aerobic bacteria counts on carcasses to various degrees (Northcutt
et al., 2003). Carcasses washers have had mixed results on reductions of Campylobacter
compared to other interventions (Bashor et al., 2004). The use of multiple carcass washing steps
for the same carcasses has shown to be more effective than any one step alone. For example, it
has been demonstrated that the use of brushes pre-scald in combination with spray washers after
feather removal, during evisceration, and prior to chilling have collectively reduced quantities of
Campylobacter and Escherichia coli, and decreased the presence of Salmonella (Berrang and
Bailey, 2009).
Continuous immersion chilling has been validated as an effective means to rapidly reduce
broiler carcass temperatures and microbiological loads (Mulder et al., 1976). Tests of water
immersion chilling as compared to air chilling have found aerobic count data to be comparable,
although immersion chilling has demonstrated a greater impact on the ability to injure or
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inactivate pathogens (Barbut et al., 2009). Immersion chilling has been found to have a negative
impact on the growth of Campylobacter (Voidarou et al., 2007). Some studies have indicated
that air chilling may have additional benefits of further reduced microbiological counts compared
to immersion chilling, and lower quantities of spoilage bacteria after held in refrigerated storage
(Tuncer and Sirelli, 2008).
Antimicrobial interventions to control Salmonella or Campylobacter can be applied in
multiple ways, such as spraying or immersion dipping (USDA FSIS, 2015). Immersion is
considered generally more effective than spraying because it ensures better coverage and longer
contact time (Buncic and Sofos, 2012). For example, acetic acid applied as an immersion dip at
20ppm has been shown to reduce Salmonella by 1.4 log colony forming units (CFU’s), compared
to a reduction of 0.8 log CFU when applied as a spray (Loretz et al., 2010).
The options for various antimicrobial technologies applied as sprays and dips have
increased in recent years for poultry processors, as requirements of regulators and consumers
have driven the marketplace to use more of these interventions. Chlorine has traditionally been
a very commonly used disinfectant in poultry plants (Buncic and Sofos, 2012), and when added
to water produces hyphochlorous acid which has lethality to microorganisms (USDA FSIS,
2015). Some other common antimicrobials used in poultry operations which have been
compared in research have included acidified sodium chlorite, trisodium phosphate, citric acid,
peroxyacetic acid, cetylpyridinium chloride (Chen et al., 2014; Del Rio et al., 2007), acidified
lactic acid, and lauric arginate (Moore et al., 2017). The effectiveness of these compounds has
frequently been shown to be dependent on contact time, concentration, pH, and application
differences in application methods, such as spray verses immersion. Best practices across plants
are often compared in research (Wideman et al., 2016).

16

Plant sanitation has been recognized as critically important in reducing microorganisms
that contribute to the growth of pathogens and spoilage organisms. Alkaline chemicals are
typically used to remove proteins, fats, oils, and greases (Marriott and Gravani, 2006), and
chlorine-based compounds such as chlorine dioxide, chlorine, or chloramines have been used to
reduce heterotrophic bacteria (Gagnon et al., 2004). Acidic compounds, such as blends of
phosphoric, nitric, sulfuric, and sulfamic acid, are used to remove encrusted surface materials
and dissolve mineral scale deposits, including those formed from alkaline cleaners (Marriott and
Gravani, 2006). To supplement cleaning compounds, sanitizing agents such as quaternary
ammonium, hydrogen peroxide, and other compounds reduce bacteria and prevent biofilms
(Dickens and Whittemore, 1997; Russell, 1998, 2000, 2008).
Overview of Alternative Interventions using Probiotics and Prebiotics to Reduce Pathogens in
Animals
Probiotics are products that contain viable microorganisms that when administered
exhibit health benefits to the host, such as regulation and stabilization of gastrointestinal barrier
functions (Gaggia et al., 2010; Salminen et al., 1996), expression of bacteriocins (Gaggia et al.,
2010; Mazmanian et al., 2008), immunomodulatory effects (Gaggia et al., 2010; Salzman et al.,
2003), and altering the microbiome of the host (Fuller, 1989; Park et al., 2013; Patterson and
Burkholder, 2003). Probiotics colonize and are metabolically active in the target site, survive
gastric juices and bile, compete with resident microbiota, and produce antimicrobial substances
antagonistic towards pathogenic bacteria (Gaggia et al., 2010). Some common genera used for
probiotics within the poultry industry are Lactobacillus, Enterococcus, Bacillus, Saccharomyces,
Bifidobacterium, Streptococcus, Aspergillus, and Candida (Gaggia et al., 2010; Kabir, 2009).
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Probiotics are derived from beneficial microbial cultures that may be administered to
stimulate the local immune system in animals (Gibson and Roberfroid, 1995; Netherwood et al.,
1999) and enhance epithelial innate immunity-related gene expression through anti-inflammatory
effects and reduced pro-inflammatory cytokine expression (Amit-Romach et al., 2010; Pagnini et
al., 2010). With the presence of microorganisms in the gastro-intestinal tract, innate immune
system associated pathogen-pattern recognition toll-like receptors may induce expression of proinflammatory cytokines and antimicrobial peptides such as defensins, which are direct effector
molecules on the innate immune response (Birchler et al., 2001; Ganz, 2003; Kaiser, 2010).
These toll-like receptors, also known as pathogen recognition receptors, are part of the innate
immune system (Rodríguez-Lecompte et al., 2012), and work by recognizing pathogenassociated molecular patterns, causing a chain reaction that stimulates the immune system to
respond (Aderem and Ulevitch, 2000).
One of the benefits of probiotics is the stimulation of the local immune system against
colonization by pathogenic microbes (Lan et al., 2005). Changes in mucin profile in response to
bacterial colonization, as a function of goblet cell numbers, have been reported to play a role
against pathogen invasion of the intestinal mucosa during early development (Forder et al.,
2007). The addition of combinations of probiotics and organic acids has been shown to increase
goblet cell numbers in the ileum of treated birds (Rodríguez-Lecompte et al., 2012), while
increasing the numbers of mucosal-adherent bacteria with a larger mucous layer in the small
intestine (Chichlowski et al., 2007).
The use of probiotics has been shown to improve the natural defense of animals against
pathogenic bacteria, and can be an alternative and effective approach to antibiotic administration
for reduction of bacterial contamination (Ghareeb et al., 2012). Salmonella reduction and control
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has been widely studied using competitive exclusion, probiotics, and enhancement of intestinal
immunity (Revolledo et al., 2006). In vitro experiments have shown that Enterococcus faecium,
Pediococcus acidilactici, Lactobacillus salivarius, and Lactobacillus reuteri isolated from
healthy chicken gut inhibit the growth of Campylobacter jejuni. Furthermore, broiler chicks
challenged with Campylobacter jejuni orally and receiving a multispecies probiotic product
containing Enterococci, Pediococci, Lactobacilli, and Bifidobacteria have exhibited significantly
reduced Campylobacter jejuni colonization in the ceca at both 8 and 15 days post-challenge
(Ghareeb et al., 2012).
Prebiotics are non-digestible food ingredients that stimulate the growth or activity of one
or a limited number of bacteria (Gaggia et al., 2010; Gibson and Roberfroid, 1995). One
prebiotic has been mannon oligosaccharides derived from Saccharomyces cerevisiae cell walls,
used as an alternative to antibiotic use in pigs (Shen et al., 2009; Rozeboom et al., 2005). Yeastbased derivatives of Saccharomyces cerevisiae and Schizosaccharomyces pombe have also been
used to express Escherichia coli phytase in order to affect broiler growth and nutrient utilization
(Onyango et al., 2004).
In cattle, use of prebiotics has been a successful alternative in some situations to the
ionophore monensin. Historically, monensin has been administered in finishing beef feedlot
diets for the prevention of coccidiosis and improved feed utilization. However, with the growing
consumer demand for “natural” and/or organically grown beef (Thompson et al, 2007),
alternative strategies to monensin have been studied, because the USDA has designated that
naturally-raised beef animals are to be grown without the use of growth hormones or
antimicrobials (USDA, 2009). An alternative that has been administered is a prebiotic derived
from Saccharomyces cerevisiae fermentation (Swyers et al., 2014). Some studies have shown
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this feed supplement to stimulate the growth of ruminal cellulolytic bacterial species by
providing soluble growth factors (Callaway and Martin, 1997), while also improving nutrient
digestibility (Wohlt et al., 1991) and increasing mineral retention (Cole et al., 1992). Also, the
use of this product has resulted in beef carcass USDA yield and quality grades that were
equivalent or better than for untreated control steers, or for those fed monensin (Swyers et al.,
2014).
Alternative microbial interventions used in live animals have been studied in the
gastrointestinal tract using multiple methods. Although healthy animals have stable microflora
in the gastrointestinal tract, molecular methods such as rRNA gene sequence amplification and
temperature gradient gel electrophoresis have been successfully used to determine the impact on
gut ecology from the use of antibiotics, probiotics, prebiotics, and other food components
(Zoetendal et al., 1998).
Saccharomyces cerevisiae and other Yeast-based Feed Supplements and their Modes of Action
in Pathogen Reduction
The yeast Saccharomyces cerevisiae is an essential component of many important human
activities including baking, brewing, distilling, and wine making. In these industries, specialized
strains of Saccharomyces cerevisiae have been selected for use, and these strains are not readily
interchangeable. In addition, this yeast compound is considered a model eukaryotic organism in
research activities in hundreds of laboratories worldwide. It has the ability to grow and function
both aerobically and anaerobically (fermentative). Wine-making and baking also involve the use
of evolving natural strains, in contrast to commercially developed yeast-based products
(Mortimer, 2000). Mannoproteins derived from Saccharomyces cerevisiae can also protect
wines from protein haze and turbidities (Dupin et al., 2000).
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Saccharomyces cerevisiae metabolism has been studied extensively as it relates to the
fermentation of cultures into alcohols, aldehydes, organic acids, esters, organic sulfides, and
carbonyl compounds. Food fermentation by yeast and lactic acid bacteria is accompanied by
aliphatic and aromatic alcohols, which at high concentrations can impart off-flavor, but at low
concentrations can make an essential contribution to the flavors and aromas of foods and
beverages (Hazelwood et al., 2008). The metabolism of yeast cell extracts via the Ehrlich
pathway including catabolism of branched-chain amino acids (leucine, valine, and isoleucine),
aromatic amino acids (phenyl-alanine, tyrosine, and tryptophan), and a sulfur-amino acid
(methionine) in a sequence of transamination, decarboxylation, reduction and export of acids and
alcohols has often been studied (Hazelwood et al., 2008). Saccharomyces cerevisiae has been an
often-used model organism to understand the molecular chemistry of cation homeostasis, an
integral characteristic of living organisms that facilitates numerous biochemical reactions by
establishing electrochemical gradients across membranes that drive cellular processes such as
transport and ATP synthesis (Cyert and Philpott, 2013).
There are differences in yeast-based feed supplements in their compositions and modes of
actions. Active dried yeast has been suggested to act mainly as a probiotic. Active dried yeast is
defined as yeast that has been dried to preserve its fermenting power and must contain at least 15
x 109 live yeast cells per gram. Dried yeast is defined as dried nonfermentive yeast separated
from its medium and must contain at least 40% crude protein (AAFCO, 2002; van Heugten et al.,
2003). Yeast culture is yeast and the media on which it was grown, dried to preserve its
fermenting power (AAFCO, 2002). Researchers have studied the differences in applying active
vs. killed dried yeast, with some studies showing effects based on form. For example,
irrespective of its viability, yeast supplementation was shown effective in reducing the duration
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of subacute ruminal acidosis beef heifers, whereas the proportion of Ruminococcus flavefaciens,
one of the major anaerobic cellulolytic rumen bacterial species (Brulc et al., 2011), was higher in
the solid fraction of digesta in heifers exposed to killed dried yeast (Vyas et al., 2014). Previous
studies have shown that autoclaved cells of Saccharomyces cerevisiae (Oeztuerk, 2009) and
Saccharomyces boulardii (Oeztuerk et al., 2005) can stimulate ruminal fermentation by
providing nutrients contained within the cells, such as vitamins or other growth factors, to
autochthonous microbiota (Opsi et al., 2012).
Yeast-based products may exhibit prebiotic effects in addition to the well-documented
probiotic effects (Vyas et al., 2014). Killed dried yeast has demonstrated prebiotic functionality
(Oeztuerk et al., 2005; Oeztuerk, 2009) via its stimulatory effects on Megashaera elsdenii
(Chaucheyras et al., 1995; Chaucheyras et al., 1996) in vitro by providing various growth factors,
pro-vitamins, and micronutrients to the autochthonous microbiota (Opsi et al., 2012). The
stabilizing effect on ruminal pH in cattle has been ascribed to reduce lactate concentration, due to
the nutritional competition between Saccharomyces cerevisiae and lactic acid producing bacteria
(Chaucheyras et al., 1996) and the stimulation of lactic acid utilizing bacteria such as
Selenomonas ruminantium (Nisbet and Martin, 1991; Callaway and Martin, 1997) and
Megasphaera elsdenii (Callaway and Martin, 1997).
Live yeast forms of Saccharomyces have been used in a variety of applications as a
preventive and therapeutic agent for the treatment of intestinal diseases in humans and animals
(Zanello et al., 2009). Saccharomyces cerevisiae has been used to suppress the effects of
aflatoxicosis in broilers (Stanley et al., 1993). Pathogenic Escherichia coli colonization of the
digestive tract is mediated by binding of bacterial ﬁmbriae to ligands on gut epithelial cells. The
inclusion of yeast components in animal feed is a promising strategy to reduce colibacillosis.
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Microscopy has conﬁrmed the ability of enterotoxigenic Escherichia coli (ETEC) to adhere to
yeast cell walls, indicating the ability of certain yeast cell wall products to contain and/or reduce
the intestinal infection from ETEC in young pigs due to the afﬁnity of ETEC to yeast cell walls
(Trevisi et al., 2012).
Researchers have repeatedly demonstrated agglutination of pathogenic bacteria onto
brewers dried yeast products (Kogan and Kocher, 2007; White et al., 2002). When agglutination
of pathogenic bacteria by a yeast extract was tested, one study found 64% of Escherchia coli
strains that were tested and 67% of Salmonella spp. strains that were tested were found to
agglutinate to the yeast product, with the pathogen strains Salmonella Typhimurium and
Salmonella Enteritidis having very high agglutination rates of 70% and 86%, respectfully
(Kogan and Kocher, 2007).
Anaerobically fermented yeast products are a rich source of nutritional metabolites,
mannanoligosaccharides, and β-glucans that may optimize gut health and immunity, which can
translate into better growth performance and a reduced risk of foodborne pathogens (Price et al.,
2010). Enteric Salmonellosis has been reported to alter microbial ecology, specifically
increasing Clostridia in the murine gastrointestinal tract prior to diarrhea (Barman et al., 2008).
Consumption of Saccharomyces cerevisiae fermentation product altered the microbial
composition of the gastrointestinal microbial community in pigs, resulting in increased
Bacteriodetes and Lactobacillus after an infection with Salmonella. Fecal shedding of
Salmonella increased from pigs fed a diet with Saccharomyces cerevisiae fermentation product,
with an increase of beneficial bacteria remaining within the gastrointestinal tract. The addition
of Saccharomyces cerevisiae fermentation product to the diets of weanling pigs resulted in
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healthier intestines, and greater compensatory body weight gains after infection with Salmonella
than pigs fed conventional nursery diets (Price et al., 2010).
Yeast cells are natural mannose-rich products that can be used as substrates for adhesion
of Gram-negative bacteria (Badia et al., 2012). Mannose-rich compounds are believed to mimic
the host cell receptor to which the pathogen adheres, as pathogen ﬁmbriae bind to these residues
instead of the mannose units of the glycoproteins on the intestinal surface (Gedek, 1999).
Mannan ologosaccharides derived from Saccharomyces cerevisiae come from yeast cell walls
containing approximately 45% mannose residues (Tizard et al., 1989).
Gram-negative bacteria have been shown to be agglutinated by mannan oligosaccharide
products by interacting with mannose-specific lectins on the surface of the bacterial organisms
(Burkey et al., 2004). Fimbriae of many bacteria bind to the mucosa of the host intestine,
facilitating proliferation of the bacteria (Holland, 1990) by acting as surface lectins, which are
carbohydrate-binding proteins (Berg et al., 2007). The cell walls of yeasts such as
Saccharomyces cerevisiae contain mannon components, which can be isolated industrially to
produce feed additives known as mannan oligosaccharides (Spring et al., 2000). This product
has been shown to bind, in vitro, to bacterial cells possessing Type 1 fimbrae, including species
of Escherichia coli and Salmonella (Spring et al., 2000), preventing these pathogens from
proliferating at the mucosal surface of the intestine (Rozeboom et al., 2005). This mechanism
works in contrast to the infectious activity of Salmonella fimbrial adhesins to host mucosa and
epithelial cells, which mediates multiple mechanisms during the initial phase of an acute
infection (Baumler et al., 1997).
The supplementation of animal diets has been studied with phosphorylated mannans
derived from the yeast cell wall of Saccharomyces cerevisiae. Mannans have the ability to alter
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microbial populations in the intestinal tract. It has been suggested that this modification is
accomplished by the ability of mannans to attach to mannose-binding proteins on the cell surface
of some strains of bacteria, thereby preventing these bacteria from colonizing the intestinal tract
by interfering with the binding carbohydrate residues on the epithelial cell surfaces (Spring et al.,
2000). Other studies using in vitro colon simulation techniques have suggested that this live
yeast probiotic can improve digestion, especially when used at higher doses, due to a shift in
bacterial populations (Pinloche et al., 2012).
Glucans with β-1,3 and β-1,6 glycosidic linkages (i.e. β-glucans) are major structural
components of yeast and fungal cell walls (Jorgensen and Robertsen, 1995) and have
antimicrobial properties by enhancing the immune function (Hetland et al., 2000).
Beta-glucans are immunomodulators that can be extracted from the cell walls of yeasts, fungi,
and some grains (Eicher et al., 2006). They can enhance the innate immune system by providing
protection against bacterial diseases (Onderdonk et al., 1992), protozoan infections (Goldman
and Jaffe, 1991), and viral illnesses (Rouhier et al., 1995). Some of the mechanisms of action
have been shown to include activation of macrophages, neutrophils, and natural killer cells,
along with B- and T- lymphocytes (Eicher et al., 2006). Also, β-glucans have been shown to
increase phagocytosis and cytokine production in macrophages in vivo (Seljelid et al., 1987) and
in vitro (Hoffman et al., 1993).
Studies have shown that the yeast survival rate all the way through the gastrointestinal
tract of pigs was 1% (Pinloche et al., 2012), which is consistent with other studies using a rat
model showing that the major loss of Saccharomyces cerevisiae happened in the large intestine
rather than in the stomach and small intestine (Garrait et al., 2007). Also, when analyzing the
changes in microbiota in the intestine caused by Saccharomyces cerevisiae, by using restriction
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fragment length polymorphism, a change was observed in solid-associated bacteria; this was
believed to be due to high concentrations of Saccharomyces cerevisiae (5 x 1011 cfu/kg) in test
feeds compared to controls with no supplements (Pinloche et al., 2012). In porcine livers,
cytokine responses have been observed in response to feeding various sources of β-glucans
derived from beneficial microorgansims such as Saccharomyces cerevisiae, Laminara digitata,
and Laminara hyperborean (Ryan et al., 2012b), which is consistent with the view that β-glucans
prime the immune system, thereby altering subsequent responses to infection (Volman et al.,
2008). It has been reported that stimulation of TLR-4 by lipopolysaccharides in the liver results
in production of pro-inﬂammatory cytokines such as certain interleukins by the Kupffer cells
(Seki et al., 2002). A mouse (Mus musculus) model of sepsis has also demonstrated that a
selected soluble poly-glucan induced signiﬁcant decreases in IL-6 and IL-10 plasma levels and
bacterial colonization of the liver (Newsome et al., 2011). From a therapeutic perspective it is
desirable to have the ability to prime host defenses without contributing to a systemic
inﬂammatory response. Differences were evident between the Laminara digitata and Laminara
hyperborea supplementation groups with respect to interleukin expression in the liver, which is
consistent with the view that there are differences in how different soluble and insoluble βglucans are absorbed (Sweeney et al., 2012). The ﬁndings of the study indicated that
supplementation with β-glucans had systemic effects on the inflammatory response in the liver to
a lipopolysaccharide challenge, although it was undetermined whether these effects were
attributable directly to the β-glucans following their absorption and uptake within the liver or
indirectly due to alterations in the gut microbiota brought about by the β-glucans (Ryan et al.,
2012a).
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Beneficial changes in bacterial populations induced by Saccharomyces cerevisiae intake
may be most effective during periods of long sickness, which may be especially relevant in some
animals with prolonged exposure to pathogens (Price et al., 2010). Additionally, Saccharomyces
cerevisiae var. boulardii used as a direct-fed microbial in monogastrics has been shown to lead
to beneficial microbiome shifts and improved intestinal health (Everard et al., 2014; Feizizadeh
et al., 2014). Also, animals fed yeast products tended to have higher serum IgG quantities than
controls, enhancing certain other serum immunological traits (White et al., 2007). In addition,
experimental phytase enzyme preparations have been developed from genes derived from
environmental Escherichia coli and cloned into Saccharomyces cerevisiae after undergoing gene
site saturation mutagenesis to increase thermal stability of the enzyme (Silversides et al., 2004).
Saccharomyces cerevisiae Metabolite Compounds Manufacturing and Administration to
Poultry and Livestock
Concentrated β-glucans are extracted from the cell walls of Saccharomyces cerevisiae in
baker’s yeast in various methods. Extraction may be achieved by adding various chemicals such
as sodium hydroxide, hydrochloric acid, and hydrogen peroxide to the yeast, in various stages
under high heat and pressure, resulting in a highly concentrated β-glucans product (Hunter et al,
2002; Li et al., 2006). Saccharomyces cerevisiae strains LL74 and LL83 have been isolated
from bakery by-products and found to have probiotic and anti-mycotoxin effects, and were able
to tolerate simulated gastrointestinal conditions, while demonstrating a potential to be used in
animal feeds, with or without antibiotics, while providing probiotic properties (Poloni et al.,
2017).
Saccharomyces cerevisiae has been effectively distributed in various methods to animal
feeds. One method studied included adding the organism into silages typically used to feed dairy

27

cattle in order to study the impact of Saccharomyces strains delivered to ruminants. In that
study, two strains of Saccharomyces cerevisiae and one strain of Saccharomyces paradoxus were
inoculated individually onto corn forage that was ensiled in mini silos. Fermentation
characteristics of silage inoculated with a strain of Saccharomyces cerevisiae were similar to
control silage. One strain of Saccharomyces cerevisiae treatment of inoculation increased ash
and decreased organic matter contents of silage, but no differences were observed in nutrient
composition or fermentation profiles after 90 days of ensiling. Inoculation with Saccharomyces
had no detrimental effect on the aerobic stability of silage. In vitro dry matter disappearance, gas
production, and microbial protein synthesis were not affected by Saccharomyces cerevisiae
inoculation. Both Saccharomyces cerevisiae and Saccharomyces paradoxus populations
increased when exposed to aerobic conditions (Duniere et al., 2015).
In another study, Saccharomyces cerevisiae supplements were distributed in whole milk
to male pigs within three hours of birth and then daily for two weeks until weaning, and
distributed in feed for an additional two weeks concurrently with another treatment that was fed
the Saccharomyces cerevisiae supplement in combination with Vitamin C. An intravenous
lipopolysaccharide challenge with Escherichia coli 0111:B4 was given at 14 days post-weaning.
The Saccharomyces cerevisiae treatment, alone and in combination with Vitamin C, increased
body weight and average daily gain, and reduced blood cortisol concentrations. After the
lipopolysaccharide challenge, within 2 hours of injection differences were observed in the
immuno-modulation factors in the combination treatment as compared to the untreated control
group, expressed by reduced tumor-necrosis factor - α mRNA in the intestine, spleen, and liver
(Eicher et al., 2006). In a separate study, pigs fed Saccharomyces cerevisiae cultures within a
pelleted and non-pelleted diet displayed no difference in animal performance based on the type
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of administration, with both application methods affecting daily intake and gain:feed ratio
(Mathew et al., 1998).
In another experiment, Holstein steers received daily treatments of Saccharomyces
cerevisiae var. boulardii with abomasal pulse doses using a veterinary stomach pump over an 18
day period, followed by pulse dose treatments of oligofructose. These doses resulted in
stabilization of the intestinal environment during increased carbohydrate fermentation (Gressley,
et al., 2016).
Live yeast Saccharomyces cerevisiae subspecies boulardii were administered to beef
heifers via oral paste at the beginning of the experiment (upon arrival to a feedlot), followed by
0.5 grams per animal per day in the diet for 35 days. This combination of paste and dietary
administration of Saccharomyces cerevisiae, in conjunction with florfenicol treatments upon
arrival to a feedlot, was demonstrated to decrease morbidity from bovine respiratory disease, but
had little effect on performance as measured by average daily gain and dry matter intake (Keyser
et al., 2007).
Saccharomyces cerevisiae has been administered not only as a single probiotic or
prebiotic, but also in combination with other supplements and treatments. The combined effects
of probiotics and/or prebiotics have been studied repeatedly and the effects appear to be
conserved across multiple species in the case of using Saccharomyces cerevisiae with other
treatments. For example, the combined effects of various combinations of Saccharomyces
cerevisiae, Lactobacillus acidophilus, Lactobacillus casei, Streptococcus faecium, sorbic acid,
and citric acid on intestinal morphology and expression of immune-related genes in young
chickens was investigated, as measured by the presence of toll-like receptors and cytokine
expression. Birds supplemented with combined probiotics and organic acids showed a beneficial
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response, with birds supplemented for 7 days exhibiting similar responses as those supplemented
for 14 days, indicating shorter periods of supplementation might be enough to elicit beneficial
responses. Some of these beneficial responses included improved villus height in the duodenum,
increased number of goblet cells, and greater expression of toll-like receptors and cytokines in
the cecum (Rodríguez-Lecompte et al., 2012). In another study, administration of
Saccharomyces cerevisiae in combination with Bacillus amyloliquefaciens improved the
intestinal microflora and morphology in broilers (Teng et al., 2017). In a study of weaned
piglets, those fed a successive probiotic supplement of Saccharomyces cerevisiae ssp. boulardii
followed by Pediococcus acidilactici realized positive effects on feed conversion, intestinal
villus length, and crypt depth, with dramatic reductions of fecal Escherchia coli counts (Le Bon
et al., 2010). A combination of Bacillus and active yeast cultures fed to weaned pigs resulted in
improved average daily gain, dry matter digestibility, and feed conversion (Min et al., 2004).
Traditionally broiler feed supplements have been combined with vaccines or other
compounds to prevent coccidiosis. In one study, four tests groups were compared: a group
exposed to a coccidiosis vaccine, a group with the coccidiosis vaccine and a Saccharomyces
cerevisiae - based feed supplement called Original XPC™ (Diamond V, Cedar Rapids, IA), a
group with the coccidiosis vaccine and salinomycin sodium in the grower diet, and a group
exposed to all treatments including the coccidiosis vaccine, salinomycin sodium supplement, and
Saccharomyces cerevisiae XPC product. The inclusion of the Saccharomyces cerevisiae - based
feed supplement decreased the prevalence of Salmonella in the broilers exposed to this treatment.
Salmonella frequencies in the ceca were reduced the greatest in the group exposed to all three
treatments, at all ages sampled including 16 days, 28 days, and 42 days. Similar results occurred
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with improvements in growth rate, body weight and feed intake on the birds exposed to XPC,
with the greatest benefits occurring from birds exposed to all treatments (Roto et al., 2017).
Research Studies Regarding the Effectiveness and Modes of Action when Administering
Saccharomyces cerevisiae Products to Various Species
Saccharomyces cerevisiae derivatives have been successfully used in multiple species for
a variety of functions. For example, this microorganism has been used for improvements in
intestinal health and strength, improved digestion and nutrient uptake, reduced dependence on
antibiotics, and improved immune response. This is in addition to other ancillary benefits such
as beneficial microbial action during certain types of food production, wine making, brewing,
and other uses. Benefits of this yeast component when administered to various animal species
are discussed below.
Humans
Derivatives of Saccharomyces cerevisiae have been routinely and extensively used for
human foods for many centuries for various purposes, such as in the production of yeast
leavened breads and fermented beverages such as beer and wine. Yeast glucans for
Saccharomyces cerevisiae also occur naturally in other human food products (EFSA, 2011). The
most common yeasts, Saccharomyces cerevisiae and Saccharomyces boulardii, have a ‘generally
recognized as safe’ (GRAS) status and have been used as probiotic biotherapeutic agents against
selected human digestive pathologies. In recent decades, Saccharomyces cerevisiae has become
an attractive host for the production of recombinant proteins and genetic bioconversion because
of the relative ease of use and high productivity in genetic engineering (Blanquet et al., 2001).
This has led to novel biotechnological research within this yeast compound. For example,
mucin-type human glycoproteins have been produced within Saccharomyces cerevisiae cells and
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may contain many types of glycoprotein forms specific to cancer cells, and thus could serve as
tumor-specific antigens used to develop cancer diagnostic and therapeutic agents, such as antiepitope antibodies (Amano et. al, 2008). In another novel experiment, elemental magnesium
administered within a Saccharomyces cerevisiae yeast biomass has been shown more effective at
penetrating the intestinal cell wall and becoming absorbed than traditional pharmacological
supplementation with magnesium salts (Malgorzata et al., 2006).
Probiotics in humans have been postulated to work with multiple modes of action. These
include suppression of viable bacterial counts through competition for nutrients or adhesion sites,
production of antibacterial compounds, changes in enzyme activity of microorganisms, and
stimulation of immunity through increased antibodies and macrophages (Fuller, 1989).
Researchers have shown that Saccharomyces cerevisiae var. boulardii is a preventative and
therapeutic agent in humans through various mechanisms including inactivation of bacterial
toxins, nutritional effects, quorum sensing, trophic effects, immune-modulatory effects, antiinflammatory effects, and epithelial cell restitution and maintenance of barrier integrity
(Łukaszewicz, 2012). The influence of yeasts was shown to shorten the lag phase duration of
bacterial proliferation, while binding pathogenic bacteria to the yeast cell surface, limiting
bacterial invasiveness and preventing bacterial adherence and translocation in human intestines
(Rajkowska et al., 2012). This has also been demonstrated in other clinical trials, where pooling
data from multiple trials and sources of information on acute childhood diarrhea have shown that
Saccharomyces boulardii signiﬁcantly reduced the duration of diarrhea by 19.7 hours, stool
frequency on day 2 and 3, and the risk for diarrhea on days 3 and 4 after intervention, as
compared to untreated control subjects (Feizizadeh et al., 2014). Other studies have shown that
Saccharomyces boulardii has helped reduce or prevent antibiotic-associated diarrhea, travelers
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diarrhea, enteral tube feeding diarrhea, acquired immune deficiency syndrome (AIDS) associated
diarrhea, inflammatory bowl syndrome and disease, and recurrent diseases associated with
Clostridium difficile (Zanello et al., 2009). Prebiotics such as non-digestible oligosaccharides
and fructooligosaccharides have been shown to modulate human lipid metabolism via
fermentation modes of action, stimulating the growth of endogenous Bifidobacteria such that
after a short dosage period these become predominant in human feces (Gibson and Roberfroid,
1995). In general, probiotics have been shown to restore the integrity of the ‘‘protective’’
intestinal mucosa-related microbiota that reduce inflammatory barrier diseases of the lower
gastrointestinal tract (Kühbacher et al., 2006). Some researchers suggest that probiotic bacteria
may stimulate the intestinal innate defense mechanisms through the regulation of induction of
antimicrobial peptides such as human beta-defensin-2 (hBD-2), enhancing mucosal barriers to
harmful luminal bacteria (Wehkamp et al., 2004). This is supported by the fact that human tolllike receptor 2 meditates induction of the antimicrobial peptide hBD-2 in response to bacterial
lipoproteins (Birchler et al., 2001).
Monogastric Animals
The effects of feeding Saccharomyces cerevisiae supplements and related compounds to
monogastric animals have been studied, for example in horses, dogs, pigs, and fish. Learnings
from other species can provide insight to broilers as many physiological characteristics are
similarly conserved across species. The impact on these species is discussed below.
Healthy horses fed supplemental Saccharomyces cerevisiae metabolites in research did
not realize any effect on total nutrient digestibility (Mackenthun et al., 2012). However,
supplementation to horses was found to have beneficial effects on the equine fecal bacterial
communities and blood stress markers. Stimulation of lactate-utilizing bacteria in the large
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intestine was studied and may possibly be explained by the supply of growth factors from yeasts,
as fecal concentrations of lactate-utilizing bacteria and cellulolytic bacteria were greater in
supplemented horses than in control horses. Transportation for 2 hours disturbed the fecal
bacterial ecosystem in horses, increasing the risk of triggering microbial dysbiosis on a longer
term in the large intestine, and Saccharomyces cerevisiae supplementation may have helped
reduce the negative impact of transportation on the equine fecal bacterial ecosystem (Faubladier
et al., 2013).
In a study of horses fed a high-fiber or a high-starch diet, with or without Saccharomyces
cerevisiae supplements, it was determined that the activity of most enzymes, such as
polysaccharidase and glycoside hydrolase β-D-xylosidase, increased after the addition of
Saccharomyces cerevisiae supplement (Jouany et al., 2009). Yeast cultures of Saccharomyces
cerevisiae added to fecal samples collected from mature horses on a high fiber diet were found to
decrease ammonia concentrations when the samples were incubated, and increased acetate
production in fecal samples from horses exposed to a diet containing highly concentrated pellets
(Lattimer et al., 2007). A Saccharomyces cerevisiae supplement had a significant effect on the
microbial profile and fermentation pattern in the large intestine of horses fed a high-fiber and
high-starch diet, such as modification of gut pH, concentrations of lactic acid and ammonia.
When the digestion of starch by equine in the small intestine has been saturated, the effect of
adding Saccharomyces cerevisiae in the diet has limited the extent of overall undesirable
changes in the intestinal ecosystem of the horse (Medina et al., 2002). Another study has shown
yeast products with added Selenium can increase the blood concentrations of this element vs.
controls (Calamari et al., 2009).
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The effects of live yeast Saccharomyces cerevisiae have been studied in dogs. When
Saccharomyces cerevisiae strain CNCM I4407 was administered to beagle dogs, treated beagles
had greater weight gain, higher digestibility of neutral detergent fiber, and lower Escherichia coli
and enterococci counts in feces (Stercova et al., 2016). This was consistent with other studies
using spray-dried Saccharomyces cerevisiae in dog diets with similar reductions in Escherchia
coli counts and increased nutrient digestibility (Middelbos et al., 2006, 2007).
In pigs, Saccharomyces cerevisiae cultures have immunologically enhanced of intestinal
functions. Yeast products improve pig health by various mechanisms, including inhibition of
pathogen adhesion to gastrointestinal epithelial tissues, stimulating immune cells, and adsorption
of mycotoxins and inhibiting their actions (Kogan and Kocher, 2007). Pigs experimentally
challenged with Escherichia coli K88 along with being fed yeast cultures of Saccharomyces
cerevisiae had reduced quantities of C-reactive proteins in the blood and reduced toll-like
receptors in the intestine (Badia et al., 2012). The inclusion of mannan ologosaccharides from
yeast in pig diets has contributed to overall animal health and growth through multiple
mechanisms, including decreasing pathogenic bacteria (Connolly, 2001). An oral administration
of Saccharomyces cerevisiae was found to reduce the mortality in pigs associated with immune
and cortisol responses to Escherichia coli. This may have occurred via suppression of acute
responses to pathogenic challenges and, thereby, preventing the diversion of energy away from
maintaining innate and adaptive immune responses, as well as liberating it for growth-related
purposes. Also, the cumulative Saccharomyces cerevisiae induced immune-neuroendocrine
response to the lipopolysaccharide (Escherichia coli) may have presumably functioned to
facilitate short-term clearance of the pathogen, wheras prolonged regulation of the immune
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response may have occurred due to heightened cytokine production at the cellular level (Collier
et al., 2011).
A feed additive containing multiple components, including processed yeast cell walls as a
protein source, improved average daily gain, body weights, feed intake, and innate immunity in
pigs at 14 days post-weaning compared to controls (Gerritsen et al, 2012). Other studies showed
only a marginal effect of yeast-based β-glucans on the immune response, being less effective
than certain antibiotics (Hahn et al, 2006). Physiologically, pigs fed Saccharomyces cerevisiae
have had a thicker colon wall on day 10 compared to those not fed yeast products, with lower
ileal and colonic digesta ammonia concentrations on days 10 and 14, reduced diarrhea, and
decreased Escherichia coli K88+ attachment to the ileal mucosa (Kiarie et al., 2012).
In pig reproduction operations, the administration of Saccharomyces cerevisiae boulardii
to sows prior to farrowing was found to modulate development of porcine mucosal immunity,
reduce intestinal bacterial translocation to mesenteric lymph nodes after a Eschericia coli
challenge, and increase IgA concentrations in ileal flushes collected from piglets on days 42 and
52 (Lessard et al., 2009). Dietary supplementation with live yeast Saccharomyces cerevisiae to
sows and piglets in the late gestation, suckling, and postweaning periods have been useful in the
reduction of the duration and severity of postweaning diarrhea (Trckova et al., 2014). This has
been shown microscopically to occur due to inhibition of certain Escherichia coli from adhering
to the brush border region of intestinal villi (Trevisi et al., 2015). In a study of weaning stress
followed immediately by transport stress, yeast supplementation suppressed neutrophil and WBC
counts that would typically increase after a stressor, wheras differences in Salmonella
occurrences in the mesenteric lymph nodes and cecum were inconclusive (Weedman et al.,
2011). Saccharomyces cerevisiae subspecies boulardii has favorably influenced the microbiota
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of the colon of weaned pigs by enhancing the establishment of Porphyromonadaceae and
Ruminococcaceae bacterial families, suggesting that this feed additive has the potential to
modulate bacterial populations associated with gut health (Brousseau et al., 2015). Also,
fermentation products of Saccharomyces cerevisiae have been shown to successfully administer
recombinant intracellular epidermal growth factor in young pigs, ameliorating stress and
preventing incomplete gastrointestinal development in early-weaned piglets (Wang et at., 2015).
Inclusion of yeast cultures in the weanling pig diets has favorably impacted feed intake and
performance (Mathew et al., 1998).
The immune systems of various species of fish have been stimulated by the use of
selected probiotics such as Saccharomyces cerevisiae, Vibrio fluviales, Aeromonas hydrophila,
Lactobacillus rhamnosus, Bacillus subtilis, and others (Gómez and Balcázar, 2007). Dietary
Saccharomyces cerevisiae fermentation products have been reported to improve growth and
survival of shrimp Litopenaeus vannamaei (Burgent et al., 2004) and rainbow trout
Oncorhynchus mykiss (Barnes et al., 2006). Also, the yeast product has been shown to improve
feed conversion and growth of hybrid tilapia, while also having a favorable impact on nonspecific immunity and increased intestinal bacterial count and diversity as compared to the use of
florfenicol antibiotics (He et al., 2011). It has also been observed that dietary Saccharomyces
cerevisiae selectively caused an increase in various bacteria in fish, including uncultured
Mycobacterium-like species, Cetobacterium-like species, and uncultured Flavobacteria-like
species, while decreasing Escherichia coli-like bacteria, uncultured bacilli-like bacteria, and
Pseudomonas fluorescens-like bacteria (He et al, 2009). Fermented Saccharomyces cerevisiae
admininstered as a feed supplement to farm-raised rainbow trout resulted in increased feed
intake, improved feed conversion, increases in trypsin and amylase activity, and a higher density
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of goblet cells per villus in the proximal intestine (Heidarieh et al., 2013). Dietary
Saccharomyces cerevisiae has boosted the growth and immunity of juvenile Indian Major Carp
in aquaculture (Bandyopadhyay et al., 2015).
Ruminants
In dairy cattle, manipulating rumen ecology to promote lactate-uptaking microorganisms,
such as Selenomonas ruminantium and Megasphaera elsdenii, has been long reported to reduce
sub-acute ruminal acidosis (Owens et al., 1998). Yeast cultures of Saccharomyces cerevisiae
have been reported to stimulate lactate utilization by these organisms (Callaway and Martin,
1997), and could contribute to increased rumen pH (Chaucheyras-Durand et al., 2012).
Saccharomyces cerevisiae supplementation to dairy cattle has also increased milk production
(De Ondarza et al., 2010; Desnoyers et al., 2009). Saccharomyces cerevisiae live cells have
stimulated ruminal microorganism fermentation in vitro, with a linear increase of in vitro dry
matter disappearance, decreased lactate, and a small decrease of methane and hydrogen with hay
plus a concentrated feed (Lila et al., 2004). In China, the addition of Saccharomyces cerevisiae
to rice straw, corn stover, and corn silage was shown to improve rumen fermentation by
stimulating the number of fiber-digesting rumen microbes (Mao et al., 2013).
Holstein cattle have been studied extensively in respect to the effects of Saccharomyces
cerevisiae on digestion. Holstein steers received abomasal pulse doses of Saccharomyces
cerevisiae var. boulardii with a veterinary stomach pump. They were given doses of 0 (control)
or 10 grams per day of this live yeast derivative according to a crossover design with 18 day
periods. Also, abomasal infusions of 4 pulse doses of 0.25 g/kg of body weight oligofructose
were administered every 6 hours on day 16 of each period. During the baseline period prior to
the oligofructose challenge, there were no effects of Saccharomyces cerevisiae var. boulardii on
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fecal measures except for an increase in neutral detergent fiber digestibility, suggesting that the
yeast product increased intestinal fiber fermentation. During the oligofructose challenge,
Saccharomyces cerevisiae var. boulardii increased the fecal consistency score (1 = watery to 5 =
solid: Hulsen, 2006), and tended to reduce fecal short-chain fatty acids. This research suggested
that Saccharomyces cerevisiae var. boulardii abomasal treatments stabilized the intestinal
environment during increased carbohydrate fermentation (Gressley et al., 2016).
Holstein heifers fed yeast cultures of Saccharomyces cerevisiae were studied to
determine the effects of this supplement on rumen microbial fermentation under a dietary
challenge with 10:90 forage-to-concentrate ratio to induce digestive upsets. While the addition
of yeast cultures during the dietary challenge did not affect the incidence or time to digestive
upset, the study found the yeast culture reduced the foam strength in the rumen on the day after a
digestive upset, suggesting potential benefits of reducing the risk of developing bloat by using
this supplement in highly concentrated diets (Moya et al., 2009). Holstein cows fed diets
supplemented with Saccharomyces cerevisiae for 23 days prepartum and 56 days postpartum
were found to have modest postpartum improvement in body condition scores and milk
production (Robinson and Garrett, 1999).
In beef cattle, Saccharomyces cerevisiae has been successfully used for many purposes.
While the use of Saccharomyces cerevisiae in conjunction with Enterococcus faecium in feedlot
cattle diets has been shown to have little effect on reducing ruminal acidosis or improving
nutrient utilization (Beauchemin et al., 2003), feeding this combination to feedlot steers under a
high-grain diet had an effect on the animals’ immunoregulatory system, as measured by an
increase of acute phase proteins in the blood plasma, including an increase in serum amyloid A,
lipopolysaccharide-binding protein, and haptoglobin (Emmanuel et al., 2007). Although the
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impact on the host animals was not conclusive, this finding was important because it has been
reported that during conditions of inflammation, tissue injury, and infection, these acute phase
proteins are released in the liver (Suffredini et al., 1999).
Beef cattle heifers raised in Europe with a diet including Saccharomyces cerevisiae did
not realize any significant impact on growth performance, carcass quality, ruminal fermentation
products, and blood metabolites from this supplement (Carrasco et al., 2016). However, other
studies have shown that Saccharomyces cerevisiae increased feed intake and decreased the gross
energy lost as methane in cattle. This phenomenon has significant interest to some countries
interested in understanding the potential use of this organism as a tool to decrease the
contribution of this methane to greenhouse gasses (McGinn et al., 2004).
The study of biochemical structures in Saccharomyces cerevisiae has been used as a
model to research the genetic expression of sirtuins in beef cattle, which are involved in
regulation of glucose and lipid metabolism (Ghinis-Hozumi et al., 2011). Male crossbred beef
cattle fed supplementary amounts of selenium through selenium-enriched Saccharomyces
cerevisiae yeast were found to have greater activity of glutathione peroxidase in whole blood and
longissimus muscle (Juniper et al., 2008b), an important enzyme which catalyzes the reduction
of lipid and hydrogen peroxides to less harmful hydroxides through the oxidation-reduction
pathway, leading to selenocysteine (Arteel and Sies, 2001).
Yeast derived from a specific strain of Saccharomyces cerevisiae, CNCM I-3060, was
used to feed selenium enrichments to sheep at 10 times the European Union maximum, or
approximately 20 times the United States Food and Drug Administration permitted
concentration. No adverse effects were observed in animal health, performance, and voluntary
feed intake (Juniper et al., 2008a). Other studies of sheep feed supplements using
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Saccharomyces cerevisiae boulardii have demonstrated no improvement in growth performance,
possibly due to the fact that the supplement is utilized as a substrate in the rumen and digested as
a prebiotic, rather than having an effect as a probiotic (Zerby et al., 2011).
Chickens and Other Avian Species
In this section, the impact of Saccharomyces cerevisiae and other yeast-based additives
will be reviewed in respect to their impact on broilers, turkeys, and geese. In broilers, yeast
culture products have provided multiple benefits, ultimately having a favorable impact on live
bird growth performance through improved intestinal morphology, while stimulating increased
immunomodulatory functions, such as increased concentration of serum lysozyme that breaks
down the polysaccharide walls of many types of bacteria (Gao et al., 2008). The impacts on
broilers are summarized below in respect to improved intestinal morphology, reduced pathogenic
bacteria, improved broiler performance, and improved meat and egg characteristics.
Improved Intestinal Morphology
In morphometric studies of villus length, an increase has been shown in the ileum for
larger-sized birds with diets including Saccharomyces cerevisiae (Baurhoo et al., 2007;
Chichlowski et al., 2007; Morales-López et al., 2009; Solis de los Santos et al., 2005). Similarly,
the efficacy of using a Saccharomyces cerevisiae cell wall product derived from the brewery
industry had a beneficial influence on broiler performance and intestinal mucosa development, in
both litter-floor pen trials as well as field tests (Santin et al., 2001). Researchers have considered
that villus development is not a direct effect of yeast-based β-galactomannans on mucosal
development, but rather it is an indirect effect exerted by an increase in the population of
Lactobacillus and Bifidobacterium (Baurhoo et al., 2007; Solis de los Santos et al., 2005). In a
study comparing the effects of a blend of supplements to chicken diets, which included organic

41

acids, Saccharomyces cerevisiae, and various probiotics, researchers found a difference in the
intestinal structure with improved duodenal villus height based on histomorphological
assessment (Rodríquez-Lecompte et al., 2012). Birds fed yeast cell wall extract and challenged
with necrotic enteritis exhibited increased villus height, decreased crypt depth, and increased
villus:crypt ratio when challenged, and did not realize a performance decline from necrotic
enteritis (M’Sadeq et al., 2015).
Reduction of Pathogenic Bacteria
In vitro studies have shown that yeast fermentation metabolites reduced Salmonella
Typhimurium in an anaerobic mixed culture derived from chicken ceca mixed with ground
chicken feed (Rubinelli et al., 2016). Birds fed a diet supplemented with Saccharomyces
cerevisiae and challenged with Salmonella enteritidis demonstrated decreased prevalence of the
pathogen in the ceca, cloaca, and carcass skin as compared to control diets, while improving feed
intake in Salmonella challenged birds (Mountzouris et al., 2015).
Studies have shown that chickens fed diets containing β – galactomannans, such as
Saccharomyces cerevisiae, have realized reduced bacteria through various mechanisms. One
mechanism is an increase in the presence of goblet cells, which stimulate the formation of a
mucous blanket in the intestine with a large surface area for Salmonella adhesion (Baurhoo et al.,
2007; Chee et al., 2010; Chichlowski et al., 2007; Leforestier et al., 2009). Another benefit to
chickens fed β – galactomannans is the production of a physical protective barrier for the
epithelium of the ileum and in the cecal tonsil, causing a reduction of bacteria attached to the
epithelium by blocking access to these tissues (Brufau et al., 2015). Scanning images and
transmission electron microscopy have revealed a high bacterial load in the mucous blanket, both
in the ileum and in the cecal tonsil, and a reduction of bacteria attached to the epithelium in
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animals fed β-galactomannans in comparison with animals not fed these treatments (Brufau et
al., 2015). This bacterial adherence to the mucus layer has been described as occurring through
either lectins or low-affinity bonds (Barnett et al., 2012). Saccharomyces-based products in
various forms have significantly reduced Salmonella, Campylobacter, and other pathogens in the
broiler cecum or intestinal tract (Fanelli et al., 2015; Guyard-Nicodème et al., 2016; Lensing et
al., 2012; Line et al., 1998; Roto et al., 2017). Also, broilers supplemented with a yeast
autolysate derived from Saccharomyces cerevisiae realized decreased Escherichia coli counts in
digesta, increased serum antibody titers, and decreased pH of jejunal and ileal digesta compared
to birds fed a control diet (Yalçin et al., 2013).
In other studies, Saccharomyces cerevisiae-related compounds have been found to reduce
pathogens. In a study of competitive exclusion products, a Saccharomyces cerevisiae culture,
and a Pediococcus acidilactici culture, all treatments reduced Salmonella percentages in the
litter, ceca, and carcass in both summer and winter tests (Al-Zenki et al., 2009). Dietary
supplementation with 0.5 g / kg of Saccharomyces cerevisiae live yeast in broilers has resulted in
alleviation of lipopolysaccharide-induced inflammation, including increased blood serum α-acid
glycoprotein, lower serum nitric oxide content, and lower interleukin in the spleen (Wang et al.,
2016). Also, poultry exposed to Saccharomyces cerevisiae-derived 1,3 β-glucan and/or
Escherichia coli-derived lipopolysaccharide demonstrated immune modulations of airborne
pathogen-associated molecular patterns, although they were age and breed dependent
(Parmentier et al., 2006). In a trial with broiler chicks in which 3-day-old chicks were orally
challenged with 104 colony forming units of Salmonella typhimurium 29E, birds that received a
Saccharomyces cerevisiae yeast cell wall preparation had a 1 log reduction of Salmonella
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typhimurium 29E in the ceca at day 10, and other chicks challenged with Salmonella dublin had
34% reduction of that organism in ceca samples at day 10 (Spring et al., 2000).
In a comparison of bacterial interventions in broilers, a monoglyceride mixture, 5
compounds made from various short-chain fatty acids, 2 compounds derived from plant extracts,
3 probiotics, and 1 prebiotic-like compound were studied. The research resulted in the prebioticlike compound based on Saccharomyces cerevisiae yeast to have the highest impact on reduction
of Campylobacter colonies, at over 3 log10, colonies at 42 days of age (Guyard-Nicodème et al.,
2016). This may be an especially effective food safety intervention, because according to some
researchers, reducing Campylobacter colonization in cecal contents by 2 to 3 log10 would be
estimated to reduce human campylobacteriosis cases attributable to broiler meat by 76 to 90%
(Romero-Barrios et al., 2013).
Improved Live Bird Performance
Saccharomyces cerevisiae supplements have caused improved breeder, broiler, and layer
performance, to various degrees. The impact of this product has effects on a wide number of
performance measures, supporting research that has suggested a mature and stable microbiome is
an effector of improved growth performance, pathogen control, reduced mortality, and overall
health of the host (Patterson, 2012). Inclusion of yeast-based products appears to allow for the
entire microbiome of the ceca to reach its stable level at an earlier age in broiler chickens than
those in normal diets (Park et al., 2017).
Studies of breeder and layer hen performance have shown positive effects of feeding
supplemental Saccharomyces cerevisiae products. Breeder hens fed a Saccharomyces
fermentation product exhibited improvements in hatch-of-fertile eggs, with a reduction in egg
contamination from hens at 32 weeks. In addition, the progeny from 39-week-old hens that were
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fed Saccharomyces cerevisiae fermentation product had improved overall feed conversion and
breast meat yield compared to control-fed birds (Kidd et al., 2013). Laying hens fed basal diets
supplemented with Saccharomyces cerevisiae yeast cultures realized increased body weight, egg
weight, and serum uric acid and reduced cholesterol, without affecting other important factors
such as hen-day egg production, interior/exterior egg quality, and serum concentrations of
protein, triglycerides, and selected alanine amino transferase and aspartate amino transferase
enzymes (Yalçin et al., 2008). When challenged with coccidiosis, laying hens and broilers fed a
Saccharomyces cerevisiae fermentation product had reduced gastrointestinal damage as
measured by the occurrence and severity of lesions, increased body weight, and improved feed
conversion compared to control birds (Lensing et al., 2012; McIntyre et al., 2013).
In another study, a combination of feed supplements including Saccharomyces cerevisiae
used concurrently with Lactobacillus fermentum at multiple doses were compared to a basal diet
and a basal diet with the antibiotic chlortetracycline. In this research, average daily gain and
feed efficiency were improved in the broilers fed the probiotic diet during days 1 to 21,
exhibiting performance similar to the group fed the antibiotic; concurrently, the probioticsupplemented diets increased the intestinal mRNA expression of certain toll-like receptors at
various ages, suggesting stimulation of the immune system (Bai et al., 2013). A mixture of
Saccharomyces cerevisiae and Bacillus subtilis var. natto applied to broiler feed to obtain twostage fermentation resulted in improved broiler growth performance and feed intake in 21- and
39-day-old chickens (Chen et al., 2009). A combination of Lactobacillus plantarum,
Enterococcus faecium, Bacilllus subtilis, and Saccharomyces cerevisiae were used to produce a
fermented water plaintain (Alisma canaliculatum) compound that exhibited high tolerance to
acid, bile, and heat in the broiler gastrointestinal tract, benefitting growth, oxidative stability, and
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the composition of broiler fatty acids and meat tissues (Hossain et al., 2012). Also, broilers feed
a combination of direct-fed antimicrobials containing Lactobacillus reuteri, Bacillus subtilis, and
Saccharomyces cerevisiae realized improvements in multiple parameters, including body weight
gain, feed conversion during ages 0-7 days, greater numbers of white blood cells, and increased
plasma IgA, IgG, and IgM concentrations to counteract infections (Salim et al., 2013).
Chickens challenged with aflatoxin have responded to diets containing Saccharomyces
cerevisiae by displaying greater feed intake, body weight gain, and concentrations of albumin,
total protein, and globulin when compared to controls, along with reduced severity of
histological lesion scores in the liver and kidney (Bovo et al., 2015). In different studies, breeder
hens fed a Saccharomyces cerevisiae supplement displayed a significant reduction in toxic
effects of aflatoxin on pancreatic lipase and chymotrypsin (Matur et al., 2010), and
improvements to the immune system by increasing lymphocytes and phagocytic activity with
oxidative bursts of heterophiles (Matur et al., 2011). In addition, broilers treated with
Saccharomyces cerevisiae during an aflatoxin challenge realized protection against liver lesions
and favorable body weight gain (Osweiler et al., 2010). The addition of Saccharomyces
cerevisiae to broiler drinking water prevented the negative effects of aflatoxin in feed on the
relative weight of the liver, histopathology, biochemical parameters, and growth performance,
suggesting this yeast derivative may be used as an effective deterrent to mycotoxins (Pizzolitto et
al., 2013).
Some Saccharomyces cerevisiae fermentation products have improved immune functions
and growth performance in the presence of other challenges such as coccidia and Newcastle
diseases. Results of Gao et al. (2009) suggested by feeding the yeast metabolites to broilers
subjected to Eimeria tenella the metabolites could be a replacement for other treatments such as
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ionophores used to reduce the impact of coccidiosis in broiler flocks. Some researchers have
studied the impact of feeding a Saccharomyces cerevisiae yeast extract and prebiotic in the prestarter phase only, but this demonstrated a minimal effect on the humoral immune response to
Newcastle disease virus and infectious bursal disease throughout the production cycle of the
broilers (Silva et al., 2009).
Improved Meat and Egg Quality
The impact of Saccharomyces cerevisiae on poultry meat and egg characteristics has also
been studied. In a comparison on broilers fed a treatment of either whole yeast, Saccharomyces
cerevisiae yeast extract or Saccharomyces cerevisiae yeast cell wall, meat tenderness of raw and
boiled samples, as measured by a mechanical shear test, was improved in selected samples from
birds fed the whole yeast or yeast extract supplement. Also, the yeast extract and yeast cell wall
treatments resulted in lower 2-thiobarbituric acid reactive substance (TBARS) values of breast
meat stored for 10 days, suggesting antioxidant effects on the meat derived from broilers raised
under those treatments (Zhang et al., 2005). In addition, layers administered this feed
supplement have demonstrated decreased blood serum concentrations of triglycerides and
cholesterol, resulting in decreased concentrations of egg yolk cholesterol (Yalçin et al., 2010).
Feeding the Saccharomyces cerevisiae metabolite product XPC to turkeys has
ameliorated the reduction in appetite and growth rate following a live coccidiosis vaccination.
Feeding this product at 1.25 g/kg increased body weight of turkey hens, whether or not they were
vaccinated (Paiva et al., 2010). Male turkeys fed XPC exhibited increased feed conversion and
breast meat yield (Firman et al., 2013). In geese, a commercial fermented liquid feed containing
supplementary Saccharomyces cerevisiae and Bacillus subtilis var. natto was found to improve
bird growth, feed intake, and the antioxidative status of organs and breast muscle, while
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decreasing blood cholesterol. Also, this feed additive mixture improved the indigenous
microflora of the geese, due to the fact that the fermented feed contained increased lactic acid
and had a low pH, modulating the bacterial ecology of the intestine (Chen, et al., 2013).
Summary: Potential Benefits to Considering Alternative Pathogen Interventions Using
Saccharomyces cerevisiae in Poultry Production.
There are many potential benefits to considering the alternative pathogen intervention of
using Saccharomyces cerevisiae as a prebiotic or probiotic in the production of poultry and
livestock. This organism has been shown to reduce many enteric pathogens in the gastrointestinal tract by various modes, such as by providing mannose binding sites for bacteria
agglutination, enhancing the immune function with the presence of β-glucans in the gastrointestinal tract, and improving the mucin profile in the gut mucosa due to increases in the
quantity of goblet cells. This trait of Saccharomyces cerevisiae has the benefit of reducing the
dependence on antibiotics in poultry and livestock production, thereby reducing the likelihood of
antibiotic resistance. Also, these traits of Saccharomyces cerevisiae provide the added benefit of
strengthening and extending the intestinal villi brush border, leading to improved nutrient uptake
and feed efficiency, which can lead to a more economically viable animal production system,
especially in the absence of antibiotics. Although the use of Saccharomyces cerevisiae alone, or
in combination with other compounds, can be an effective strategy to improve broiler health and
reduce pathogens, some studies have indicated that the impacts of such interventions on broiler
growth and the presence of pathogenic bacteria are not as evident in flocks without disease
challenges and other stressors (Hahn-Didde and Purdum, 2016).
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ABSTRACT
Broiler production companies are continuously searching for effective feed ingredient
alternatives to optimize bird health, growth performance and carcass characteristics. To achieve
those goals, many feed additives have been developed to improve intestinal morphology and gut
bacterial profiles to maximize feed utilization and withstand disease challenges that can cause
decreased bird performance. In this study, broiler chicks obtained from a commercial hatchery
were raised in research pens to study the impact on live bird performance of administering a feed
supplement with Saccharomyces cerevisiae fermentation metabolites derived from dried yeast.
No bacterial challenges were administered to either the control, non-treated flocks, nor to the
birds administered the supplement containing Saccharomyces cerevisiae metabolites. A
comparison of control and treated flocks was conducted based on measurements of live bird
growth rate, feed conversion, and carcass yields of component parts including breast meat,
tenderloins, wings, and leg meat. The broilers treated with the Saccharomyces cerevisiae
metabolite exhibited similar live performance metrics and carcass component yields compared to
non-treated birds. In this study, the impact of feeding Saccharomyces cerevisiae metabolites to
broilers on bird performance and carcasses component yields was studied under research pen
environmental conditions in the absence of typical broiler disease challenges. In light of other
research demonstrating improved growth performance of birds feed Saccharomyces cerevisiae
metabolites in commercial settings and/or with disease challenges, results of this study suggested
that the impact of this supplement on bird performance could be more noticeable in commercial
applications than in an isolated and controlled research setting.
Key Words: Saccharomyces cerevisiae, feed supplement, broiler
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INTRODUCTION
Poultry producers and marketers continuously seek technologies to improve bird
performance, maximize carcass yields for economic reasons, and to meet customer expectations.
Some of the key measurements of broiler performance for commercial companies are growth
rates, feed efficiency, and component yields, which all have a significant impact on production
costs that ultimately affect chicken meat prices. In addition, albeit not discussed in this research
study, the costs of utilizing feed supplements to maintain bird health and reduce pathogenic
bacteria in broilers is an area of emphasis for food safety considerations. Therefore, the impact
of feed ingredients and supplements on these metrics is an area of increasing research.
Feed supplements containing Saccharomyces cerevisiae fermentation metabolites and
related compounds have been studied in multiple applications. Improved feed efficiency, weight
gain, and feed consumption at 3 weeks of age has been observed in male broilers fed a dietary
supplement of baker’s yeast (Shareef and Al-Dabbagh, 2009). Other research has demonstrated
the effects of using combinations of feed supplements in conjunction with Saccharomyces
cerevisiae. For example, in a study comparing the effects of a blend of supplements in chicken
diets, which included organic acids, Saccharomyces cerevisiae, and various probiotics,
researchers found a difference in the intestinal structure with improved duodenal villus height
(Rodríguez-Lecompte et al., 2012). A mixture of Saccharomyces cerevisiae and Bacillus
subtilis var. natto supplemented in broiler feed to obtain 2-stage fermentation resulted in
improved broiler growth performance and feed intake in 21- and 39-day-old chickens (Chen et
al., 2009). Also, broilers administered a combination of direct-fed antimicrobials including
Saccharomyces cerevisiae had improved body weight gain and feed conversion during the first
week of age, with greater numbers of white blood cells and increased plasma antibodies and
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immunoglobulins to counteract infections (Salim et al., 2013). In turkeys, feeding a
Saccharomyces cerevisiae fermentation product has ameliorated the typical reduction in appetite
and growth rate following a live coccidiosis vaccination (Paiva et al., 2010), as well as increased
feed conversion and breast meat yield (Firman et al., 2013).
The use of feed supplements containing yeast-based compounds, such as live yeast, killed
dried yeast, and Saccharomyces cerevisiae fermentation metabolites, have benefitted the
performance of other animals. The metabolites of Saccharomyces cerevisiae have been found to
increase feed intake and decrease the gross energy lost in beef cattle (McGinn et al., 2004), and
increase milk production in dairy cattle (Desnoyers et al., 2009; De Ondarza et al., 2010).
Similar feed additives have contributed to overall animal health and growth in pigs (Connolly,
2001). Farm-raised rainbow trout and juvenile carp raised in aquaculture have also realized
benefits from Saccharomyces cerevisiae metabolites, such as improved feed intake, feed
conversion, intestinal villus structure (Heidarieh et al., 2013), and immunity (Bandyopadhyay et
al, 2015). Other benefits of using Saccharomyces cerevisiae in various species are consistent
with the general advantages of administering beneficial bacteria to animals, such as reduced
pathogen contamination (Ghareeb et al., 2012), stimulation of the immune system (Gibson and
Roberfroid, 1995; Netherwood et al., 1999) and enhanced epithelial innate immunity-related
gene expression through reduced inflammation (Amit-Romach et al., 2010; Pagnini et al., 2010).
The purpose of this experiment was to determine the effectiveness of feeding a
supplement containing the dried metabolites of Saccharomyces cerevisiae to broilers on live bird
performance and carcass characteristics. Broiler chickens were raised in a controlled
environment in research pens. Control birds were fed a normal diet used in commercial broiler
operations, and treated birds were fed the same diet with an added proprietary feed supplement
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containing Saccharomyces cerevisiae fermentation metabolites, under an FDA-approved usage
rate per normal commercial practices. Comparisons were made of growth rate, feed conversion,
carcass weights, and component yields. This research was conducted to understand the impact of
administering Saccharomyces cerevisiae metabolite feed additive on the quantity of marketable
chicken carcasses and products, and the live production performance associated with the
production of those products.
MATERIALS AND METHODS
Experimental Design and Treatments
A total of 384 one-day-old broiler chicks were randomly allotted to either a control diet
(CON) consisting of feed used in commercial operations for broiler production or the same basal
diet supplemented with of 1.25 lb / ton (0.62 kg / metric ton) of a proprietary feed supplement
containing Saccharomyces cerevisiae fermentation metabolites (SCM). Each treatment
consisted of 192 broilers, divided into 8 replicate pens of 24 birds each. At one day of age,
chicks were evernly divided into each of 16 experimental pens in a controlled research barn
setting. The assignment of replicate groups to one of the 16 pens was completed in a completely
randomized block design. Environmental conditions for flock density, lighting, and temperature
were held constant across the pens, per industry standards consistent with the commercial broiler
production industry. Feeds were pelleted prior to administration. Birds were allowed ad libitum
access to feed and water throughout the life of the flocks, until feed was withdrawn prior to
processing. The birds were then processed in a pilot processing plant using normal industry
practices for harvest and processing. A total of 372 birds were captured for processing and yield
analysis, including 180 CON and 192 SCM broilers. The research protocols for this experiment
were reviewed and approved by the University of Arkansas Institutional Animal Care and Use
Committee (IACUC).
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Measurements of Broiler Performance, Carcass Yields, and Component Parts Percentages
For live production measures of feed conversion and growth, each floor pen of broilers
was the experimental unit. At 0, 15, 29, and 47days of age, total broiler weight was measured on
a pen-basis to calculate rate of gain, whereas the weights of feed administered and consumed
were recorded at each weight age to calculate the feed conversion efficiency. Mortality weights
and bird counts were collected throughout the life of the flock to adjust feed conversion by
adding mortality weights to the weights of live birds at each stage of data collection.
Individual broilers were also evaluated as individual experimental units for live weights,
carcass yields, and component parts percentages. At 48 days of age, birds were collected from
the research floor pens, weighed, euthanized, and processed at a pilot processing facility. The
processing plant used equipment typical of commercial industry operations, including in-line
poultry slaughter equipment, carcass scalding, feather removal, chilling, manual processing and
conventional hand deboning of carcasses for component yields. Prior to processing, each
individual broiler was weighed on a stationary scale, and then identified with a numbered tag
which included a bar code to maintain identity throughout poultry slaughter, chilling, and
separation and weighing of component parts. All internal viscera were removed and were not
included in the analysis. Data collected after birds were processed included the weights of the
carcasses, wings, boneless pectoralis major breast muscles, tenderloins, boneless leg meat
portions, pelvic back portions, breast skin tissues, leg meat skin, leg bones, adipose tissue from
the abdominal pelvic cavity, and the anterior skeletal frame consisting of the backbone, rib
bones, and sternum bone and cartilage material.
Statistical Analysis
Feed conversion for each experimental floor pen unit was determined as the feed
consumed ÷ weight of broilers in the pen, adjusted for mortality. For measurements of carcass
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yields and component parts percentages, the individual bird and its associated parts percentages
were the experimental units. For yield comparisons, the carcass weight from each broiler, and all
of the associated component parts, were calculated as a percent of the live weight prior to
slaughter. In addition, each component part was calculated as a percent of its associated carcass
weight, and evaluated as the component yield for each carcass. The comparative analysis was
completed with statistical software (SAS Institute, 2016), with treatments compared using the
Oneway Analysis of Variance and Student’s t Test, and tests for equal variances were conducted
using the Brown-Forsythe analysis.
RESULTS AND DISCUSSION
Broilers and other animals have shown favorable responses in some trials to feed
supplements containing Saccharomyces cerevisiae fermentation metabolites or other yeast-based
organisms. In general, however, many trials have shown that while favorable outcomes have
been evident from feeding Saccharomyces cerevisiae in reducing intestinal bacteria and
improving gut physiology, greater benefits have been demonstrated when challenges, such as
diseases, stressors, or abnormalities in feed ingredients, are introduced during the trial. In the
present study, no challenges were presented to the broilers, as they were grown in research floor
pens and harvested in a controlled environment. Therefore, this may explain why there were few
differences noted in performance measures that are considered highly relevant in the commercial
chicken industry, such as growth rate, feed conversion, and carcass yields.
The live broiler performance results are reported in Table 1. Overall, the mean growth
rates and final bird weights at harvest did not differ (P = 0.05) between the CON and SCM birds.
Also, feed conversion efficiency was not different between CON and SCM broilers, with overall
feed:gain of 1.72 and 1.71 for CON and SCM birds, respectfully. It is important to note that the
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environmental conditions were optimal in the research pens, and in a commercial operation the
differences in these results may be more apparent.
With the exception that tenderloin weights were greater (P≤ 0.05) in CON-fed than SCMfed birds, carcass component weights did not differ between the CON and SCM broilers (Table
2). Although the tenderloins weights may have been slightly different, favoring the CON
broilers, this difference was not considered commercially significant given the small percentage
of the total yield attributable to this portion. Moreover, neither carcass yields (expressed as a
percent of live weight; Figure 1) nor yields of major portions (Figure 2) and minor portions
(Figures 3 and 4) differed (P>0.05) between the CON and SCM broilers. It is not surprising that
carcass and component yields were not different between CON and SCM birds, especially
considering that neither growth rate nor feed:gain differed between the dietary treatments. The
fact that all broilers were in a tightly-controlled environment, free of commercial stressors or
disease challenges, could have been another major reason for the lack of differences observed in
carcass yields and component parts percentages.
While the use of Saccharomyces cerevisiae alone, or in combination with other
compounds, can be an effective strategy to improve broiler health and reduce pathogens, the
results of this research were consistent with other studies which indicated that the impact of
some prebiotics and probiotics on broiler growth was not as evident in flocks without disease
challenges and other stressors (Hahn-Didde and Purdum, 2016). Furthermore, the use of
Saccharomyces cerevisiae in conjunction with Enterococcus faecium in feedlot cattle diets had
little effect on nutrient utilization and growth performance (Beauchemin et al, 2003), wheras
feed supplements of Saccharomyces cerevisiae var. boulardii failed to alter growth performance
of sheep (Zerby et al., 2011).
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Results of this research differ from other studies which have indicated performance
advantages when feeding supplements containing Saccharomyces cerevisiae components. Feed
supplements including Saccharomyces cerevisiae used concurrently with Lactobacillus
fermentum at multiple doses showed improved average daily gain and feed conversion efficiency
in broilers during the first 21 days (Bai et al., 2013). In that research, diets supplemented with
Saccharomyces cerevisiae and other beneficial bacteria increased the intestinal mRNA
expression of certain toll-like receptors at various ages, indicating stimulation of the immune
system. Similar yeast culture products used as supplements in broiler diets have shown a
favorable impact on live bird growth performance through improved intestinal morphology,
stimulation of immunomodulatory functions, and increased concentration of serum lysozyme
that breaks down the polysaccharide walls of many bacteria (Gao et al., 2008). Also, broilers fed
yeast-based supplements have exhibited increased blood protein and glucose, with corresponding
increases in body weight gain at 3 weeks of age (Shareef and Al-Dabbagh, 2009). In a similar
analysis, a combination of Lactobacillus plantarum, Enterococcus faecium, Bacilllus subtilis,
and Saccharomyces cerevisiae produced a fermented water plantain (Alisma canaliculatum)
compound that exhibited high tolerance to acid, bile, and heat in the broiler gastrointestinal tract,
benefitting growth, oxidative stability, and the composition of broiler fatty acids and meat tissues
(Hossain et al., 2012).
The benefits of supplementing broiler diets with Saccharomyces cerevisiae have been
shown to be most evident when birds were challenged than when confined to a controlled
environment. For example, dietary Saccharomyces cerevisiae and other yeast-based products
have been shown repeatedly to suppress the effects of aflatoxicosis (Stanley et al., 1993;
Pizzolitto et al., 2013; Osweiler et al., 2010), which is a major challenge in the commercial
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chicken feed and production industry. Saccharomyces cerevisiae and other compounds derived
from yeast have also benefited broilers by alleviating lipopolysaccharide-induced inflammation
(Wang et al., 2016). Improved performance in broilers due to Saccharomyces cerevisiae has also
been realized by stimulation of the immune system (Bai et al., 2013; Yalçin et al., 2013). Feed
uptake and intestinal strength against invasive organisms when feeding various compounds
derived from Saccharomyces cerevisiae may be largely due to improvements in gut morphology
(Baurhoo et al., 2007; Morales-López et al., 2009; M’Sadeq et al., 2015; Solis de los Santos et
al., 2005). Other research has shown that feeds supplemented with yeast compounds have
caused reinforcement of the host’s natural defenses by increasing pathogen colonization
resistance and stimulating the immune response (Line et al., 1998). Thus, in light of previous
research, the results of this experiment suggest that although these Saccharomyces cerevisiae
metabolites did not appear to provide any significant improvements in performance or yields, the
practical benefits of the supplement may not have been observed due to the absence of any
significant challenges from environmental conditions, pathogens or other diseases.
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TABLES AND FIGURES

Table 1
Broiler Performance of Birds Fed Control Diets (CON)
vs. CON Diets plus Saccharomyces cerevisiae Metabolites (SCM)
Broiler Live Performance
Measurements

Treatment Means (kg)
CON±SEM
SCM± SEM

Feed Conversion 1

P-value

1.724 ± 0.0214

1.714 ± 0.0106

0.679

Day 0 - 15

0.028 ± 0.0005

0.028 ± 0.0005

0.690

Day 0 - 29

0.051 ± 0.0009

0.050 ± 0.0007

0.865

Day 0 - 47

0.065 ± 0.0013

0.066 ± 0.0006

0.730

3.025 ± 0.0591

3.044 ± 0.0352

0.788

Growth Rate per Day 2

Live Wt. (kg) in pens Day 47

1

feed conversion = feed:gain (kg)

2

growth rate = gain (kg) / age (d)
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Table 2
Carcass and Parts Weights of Broilers Fed Control Diets (CON)
vs. CON Diets plus Saccharomyces cerevisiae Metabolites (SCM)
Mean Weights (kg)
Component

SCM
SEM

P-value

SEM

SCM
Mean (kg)

2.392

0.0247

2.379

0.0238

0.700

Boneless Breast

0.761

0.0094

0.753

0.0089

0.532

Leg Meat

0.464

0.0061

0.468

0.0060

0.580

Wings

0.227

0.0022

0.227

0.0022

0.900

Tenderloins

0.137

0.0013

0.132

0.0014

0.004

Frame

0.263

0.0032

0.263

0.0030

0.984

Back

0.232

0.0034

0.229

0.0031

0.591

Leg Bones

0.135

0.0018

0.131

0.0016

0.138

Breast Skin

0.077

0.0012

0.079

0.0012

0.286

Leg Skin

0.064

0.0009

0.064

0.0011

0.968

Adipose

0.046

0.0009

0.046

0.0010

0.952

CON

CON

Mean (kg)
Carcass
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Yield % of Live Weight

78.4
78.2
78.0
77.8
77.6
77.4
77.2
77.0
CON

SCM
Treatment

Figure 1. Broiler Carcass Yields as Percent of Live Weight
from Birds with Control (CON) Diets vs. Birds Treated with
Saccharomyces Cerevisia Metabolites (SCM)
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Figure 2. Broiler Yields of Major Component Parts
from Birds with Control (CON) Diets vs. Birds Treated with
Saccharomyces Cerevisia Metabolites (SCM)
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Figure 3. Broiler Yields of Minor Component Frames, Backs, and
Leg Bones from Birds with Control (CON) Diets vs. Birds Treated
with Saccharomyces Cerevisia Metabolites (SCM)
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Figure 4. Broiler Yields of Minor Components Skin and Adipose
from Birds with Control (CON) Diets vs. Birds Treated with
Saccharomyces Cerevisia Metabolites (SCM)

96

CHAPTER IV

The Effects of Feeding Broilers the Metabolites of Saccharomyces cerevisiae
Fermentation on Salmonella Virulence and Antimicrobial Susceptibility in Ceca

97

The Effects of Feeding Broilers the Metabolites of Saccharomyces cerevisiae
Fermentation on Salmonella Virulence and Antimicrobial Susceptibility in Ceca

B.D. Potter*1, J.A. Marcy*, C.M. Owens*, and J.A. Apple†
* Department of Poultry Science, University of Arkansas, Fayetteville, Arkansas 72701
†Department of Animal Science, University of Arkansas, Fayetteville, Arkansas 72701

Manuscript Completion:
January 2019

1

corresponding author bdpttr@att.net

98

ABSTRACT
The reduction of Salmonella and other enteric pathogens in raw poultry products are of
interest of poultry producers, processors, and end-users. Increased emphasis is being placed on
understanding the impact that interventions have on the Salmonella virulence and antibiotic
resistance. The influence of microbial interventions in poultry on pathogen virulence and
antibiotic resistance is gaining widespread interest, with the sustainability of food safety efforts
being a major goal and concern of regulators and consumers. Commercially grown broiler
chickens from multiple farms and flocks were administered a prebiotic consisting of
Saccharomyces cerevisiae fermentation metabolites derived from dried yeast. Broilers exposed
to Saccharomyces cerevisiae were compared to non-treated chickens, with research metrics
including the virulence and antibiotic resistance of the pathogen cultures gathered from cecal
samples. The flocks treated with the Saccharomyces cerevisiae prebiotic realized reductions in
both Salmonella virulence as expressed by hilA% of controls, and also improved susceptibility of
Salmonella colonies to selected common antibiotics at the time of harvest. This reduction of
Salmonella virulence and improved antibiotic susceptibility is a significant component of
reduced risk of severe foodborne illness and the ability to effectively treat Salmonella infections
with selected antimicrobials.
Key Words: Salmonella, Saccharomyces cerevisiae, prebiotic, broiler
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INTRODUCTION
In poultry production, pathogen reduction has been an area of continual emphasis for
many years, with increasing needs to find alternative methods to reduce bacteria in a sustainable
manner.

The Food and Agriculture Organisation [sic] of the United Nations and the World

Health Organisation [sic] have stated that poultry meat has been associated frequently and
consistently with the transmission of enteric pathogens (FAO/WHO, 2002) While many
processing plants utilize a variety of pathogen interventions (Berrang and Bailey, 2009;
Shackleford et al., 1993), some consumers prefer to purchase products not treated with
antimicrobials to reduce bacteria due to concerns about chemicals and their impact on consumer
health and/or product organoleptic characteristics. Therefore, while antimicrobial interventions
have been proven effective at reducing pathogens and bacterial loads, these interventions cannot
be used exclusively for all applications. Also, the antimicrobial interventions used in processing
plants are most effective when pathogen loads are minimized on incoming animals and raw
materials prior to processing. For these reasons, research projects to find new, effective ways to
reduce pathogens in live poultry production are extensive.
Poultry producers also have the additional challenges from many consumers that have
expressed opinions toward removing antibiotics in animal agriculture. Although antibiotics have
been effectively used under veterinarian prescriptions to prevent and/or treat diseases, public
concern for creating antibiotic-resistant pathogens has led many meat and poultry processors to
seek alternatives to antibiotics in animal production operations. Audits for live animal practices
regarding antibiotic use have become a growing function of the USDA Agricultural Marketing
Service (AMS) certification system for participating companies that have live animal production
controls routinely audited under a USDA Process Verified Program (USDA AMS, 2018).

100

In order to minimize pathogens in raw poultry while reducing the use of antimicrobials
and other traditional interventions and antibiotics, many meat and poultry producers continually
seek new technologies. Salmonella reduction has been widely studied using competitive
exclusion, probiotics, and other strategies for enhancement of intestinal immunity (Revolledo et
al., 2006). Some probiotics have improved the natural defense of animals against pathogenic
bacteria, and can be an alternative approach to antibiotics to effectively reduce bacterial
contamination (Ghareeb et al., 2012). Mannon oligosaccharides derived from Saccharomyces
cerevisiae cell walls have been effective alternatives to antibiotics for some applications in meat
animals (Rozeboom et al., 2005; Shen et al., 2009). In poultry, Saccharomyces cerevisiae and
other yeast based products have been successfully used for a variety of purposes, such as
suppressing the effects of aflatoxicosis (Osweiler et al., 2010; Pizzolitto et al., 2013; Stanley et
al., 1993), stimulation of the immune system (Bai et al., 2013; Yalçin et al., 2013), and improved
gut morphology (Baurhoo et al., 2007; Morales-López et al., 2009).
The purpose of this experiment was to determine the effectiveness of feeding the dried
metabolites of Saccharomyces cerevisiae to broilers on cecal Salmonella virulence and
susceptibility to selected antimicrobials. Broiler chicken ceca were collected at commercial
processing facilities after normal processing. This study included analyses from poultry ceca
collected at the time of harvest from four different processing plants that provided samples
representing twelve different integrated broiler houses, by analyzing both control non-treated
flocks as well as flocks administered the prebiotic Saccharomyces cerevisiae product.
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MATERIALS AND METHODS
Experimental design
Broiler plants that provided samples for evaluation were located in multiple regions of
the United States. Four plants provided samples from flocks associated with their complexes,
representing a total of twelve integrated commercial farms. On each farm, one commercial
house of broilers was deemed an experimental flock. The broiler houses were located in regions
with extensive poultry production, and were overseen by best management practices typical of
the poultry industry, under the oversight of poultry veterinarian services and corporate
management. Half of the farms selected were processed at 2 plants that manufactured products
for marketing primarily as whole carcasses and bone-in parts, with less production of boneless
items. The other half of the farms selected were processed at 2 other plants designed to grow
birds for marketing a significant percentage of items as boneless portions, while also marketing
some items that included bones and skeletal frame material in addition to the muscle fragment
portions.
The experimental units were samples of ceca collected after processing in a commercial
plant, to measure Salmonella virulence and antibiotic susceptibility at the time of harvest of both
control flocks (CON), as well as the same flocks administered a Saccharomyces cerevisiae yeast
fermentation metabolite product (SCT) with an additional 1.25 lb per ton (0.62 kg / metric ton)
of concentrated product added on top of the control formulation. For the SCT samples, the
samples were collected as repeated measures over time for a total of 3 treatment repetitions.
Prior to harvest, the control flocks were fed a commercial poultry diet formulated by an animal
nutritionist to optimize broiler welfare and performance. Flock housing conditions were held
constant across the flocks in each complex, per industry standards required by broiler integrators
and consistent with the commercial chicken production industry. Feeds were manufactured at a
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commercial feed mill and pelleted prior to administration. Birds were allowed ad libitum access
to feed and water throughout the life of the flocks, until feed was withdrawn from birds prior to
catching for processing. When the broilers reached the market age for slaughter, the birds were
transported from the farm in a conventional transport coop, and then birds were harvested at a
commercial poultry processing plant under USDA inspection. The birds were processed at one
of four selected commercial facilities following published broiler welfare standards (National
Chicken Council, 2018a) that were approved by the Professional Animal Auditor Certification
Organization (PAACO) (National Chicken Council, 2018b), requiring routine auditing for best
management practices in animal wellbeing. The plant and harvesting line were held constant for
each flock during the experiment.
The second experimental period consisted of a treatment program for each flock followed
immediately after the control period. During the treatment period, flocks were grown under
identical conditions as the control period, and at harvest were measured for Salmonella presence,
quantity, virulence, and antibiotic resistance within each flock. The treatment flocks were fed
the identical commercial poultry diet as the control flock, with 1.25 lbs per ton (0.62 kg / metric
ton) of Saccharomyces cerevisiae yeast metabolite product added on top of the formula. Bird
housing was managed in a similar manner as control flocks. Feeds were manufactured at the
same commercial feed mill used for controls, pelleted, and presented ad libitum along with water
throughout the life of the flocks. Birds were processed at the same plants, using the same
procedures as the control flocks. The second experimental period continued for three cycles of
broilers on each experimental farm, grown under normal commercial conditions and processed in
the same plants and processing lines as the control flocks.
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Sampling of Broiler Ceca
Ceca samples were collected after birds were commercially processed and harvested
during normal cycles (Table 1). For sampling of ceca, after broilers were harvested by a
commercial facility, viscera were collected by commercial procedures and equipment under
USDA inspection. Ceca samples were acquired by manually removing the ceca from the viscera
by stripping it free of the intestine and pinching at the base at the ceco-colon junction. Aseptic
sampling techniques were conducted using sterile gloves and placing samples into sanitary whirlpack specimen bags. Gloves were changed between each sample collected. A total of 25 ceca
were collected after harvest from each flock sampled, and the tissues were individually packed
and stored under refrigeration before and during shipment to an offsite laboratory for analysis.
During the experiment, subgroups of 25 samples were collected per flock, with a total of 300
samples collected in the baseline group (CON), initial treated flock (SCT1), and subsequent
treated flock (SCT2), with 275 samples collected that were provided from the final treatment
group (SCT3).
Analysis of Salmonella Presence and Quantity in Broiler Ceca
Ceca samples were shipped to an independent laboratory for analysis. Each of the ceca
were weighed and then aseptically placed in 10mL of Lennox L broth (Invitrogen, Carlsbad, CA)
and manually massaged to release the cecal contents and dislodge Salmonella colonies from
adherence sites and vortexed prior to plating. An aliquot of 100µL of each mixture was
dispersed onto a Xylose Lysine Deoxycholate (XLD) agar plate (Fisher Scientific, Pittsburg, PA)
that was selective for Salmonella (Anderson et al., 2015). The agar plates were incubated
overnight at 37oC. The following day, white colonies with black centers were enumerated and
reported based on a 1:100 dilution factor as CFU/gm of cecal material or CFU/mL of rinsate.
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Measurements of Salmonella Virulence in Broiler Ceca
Cecal samples were compared for Salmonella virulence using a semi-quantitative RTPCR analysis to assess the expression of hilA (Carlson et al, 2007) in order to measure the
regulation of Salmonella invasion using this established indicator of virulence (Bajaj et al.,
1995). Total RNA was isolated from Salmonella colonies (n > 40) using the RNEasy kit
(Qiagen) per the manufacturer’s protocol. The RNA was subjected to semi-quantitative RT-PCR
using primers specific to hilA. The number of PCR cycles required to visualize an amplicon
under UV light on 2% agarose gel electrophoresis was documented. The comparative expression
of Salmonella virulence was then reported by comparing the lowest number of cycles required to
visualize an amplicon in control samples to the lowest number of cycles required to visualize an
amplicon for treated samples, expressed in percent of the number of PCR cycles required for the
control samples, using published methodology from previous research (Carlson et al., 2007).
Invasion gene expression assays were performed in triplicate for both groups (Control and Test)
for each of the flocks analyzed.
Assessment of Salmonella Susceptibility to Selected Antibiotics
The overall susceptibility of Salmonella colonies from the aforementioned cecal samples
to florfenecol, ceftiofur, and enrofloxacin was measured. Specifically, samples of Salmonella
cells recovered from the ceca of broiler chickens were obtained by selecting individual blackcentered colonies from XLD plates and inoculating them into individual dish wells containing
200μL of LB broth. The bacteria were grown overnight at 37oC to an OD600 of approximately
0.3, which corresponds to 3×108 CFU/mL. Approximately 3μL of the growth was pin-replicated
into fresh dish wells, each containing 32μg/mL, i.e. the breakpoint concentration for each of the
selected antibiotics (CLSI, 2011) in 200μL of LB broth. The percent antibiotic resistance (i.e. not
susceptible to the antibiotic) of Salmonella in cecal colonies was calculated as the percentage of
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wells in which Salmonella grew in the presence of the selected antibiotic, using published
protocols (Feye et al., 2016).
Statistical Analysis
The comparative analysis was completed with statistical software (SAS Institute, 2016).
For comparison of percentages, a Contingency Analysis of Proportions was performed using
both the Pearson’s Chisquare test, with a Likelihood Ratio analysis and Fisher’s Exact Test to
determine the probability of differences in proportions across treatments. A Kruskal – Wallis
test for population differences with unequal variances was also used to compare treatments. For
the virulence measurements, each treatment group was measured in relation to the control, and
for the analysis of antimicrobial susceptibility the results of the treatment cycles were pooled to
increase statistical power in comparison to the control group.
RESULTS AND DISCUSSION
After birds were processed in a commercial facility, ceca samples were recovered and
analyzed at a laboratory for Salmonella by selecting presumptive colonies from XLD plates and
then subjecting them to a tissue culture invasion assay. The method has previously been used
(EpiCor®, Embria Health Sciences) to understand Salmonella invasion and virulence. In this
study, the virulence of the Salmonella colonies recovered from SCT flocks was significantly less
than the virulence reported from colonies recovered from CON flocks (Figure 1). This reduced
virulence in flocks treated with SCT is consistent with previously conducted research (Gantois et
al., 2006; Possemiers et al., 2013). This difference may be attributable to the fact that
Saccharomyces cerevisiae metabolites can increase the presence and concentration of butyrate in
the intestine (Possemiers et al., 2013). Similar studies of complex fecal microbial populations
exposed to the fermentation metabolites of Saccharomyces cerevisiae have shown to effect
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volatile fatty acid production in vitro (Broomhead et al., 2012), and, more specifically, an overall
decrease of growth of specific serotypes, such as Salmonella Arizonae and Salmonella
Heidelberg (Nsereko et al., 2013). An increase in the quantity or concentration of butyrate in the
intestine has been shown to decrease Salmonella invasion as measured by gene expression in
vitro (Gantois et al., 2006). The decrease in Salmonella invasiveness has also been shown to
coincide with a decrease in the expression of hilA, which is a major regulator and indicator of
Salmonella virulence in certain animal species (Baja et al., 1995).
In addition to the study of the invasiveness and virulence of Salmonella, colonies of the
pathogen recovered from the ceca were subjected to susceptibility to florfenicol, ceftiofur, and
enrofloxacin, common drugs used in veterinary medicine that are bactericidal to Salmonella. For
each type of medication exposed to susceptibility testing, a significant improvement in antibiotic
susceptibility was observed for each of the compounds (Figure 2). While this study does not
suggest a mechanism to explain how Saccharomyces cerevisiae metabolites mediate the
improvement in antibiotic susceptibility, studies with other species have reported that this yeast
fermentation metabolite can be an important factor in dislodging antibiotic resistance-encoding
integrons from the basic Salmonella genetic structure (Brewer et al., 2013). For example, a
decrease in resistance to selected antibiotics has been observed when the loss of an SGI1
integron occurs. Traditional PCR has been used to identify the presence of the integron within
Salmonella isolates, followed by agarose gel electrophoresis to measure the sustained presences
of the integron when exposed to selected antibiotics such as chloramphenicol (Feye et al., 2016).
Further research is needed to more completely understand how Salmonella samples
collected differ in antimicrobial resistance at various stages of the poultry processing continuum.
In this research, the susceptibility of Salmonella to selected antibiotics was analyzed by
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collecting samples from cecal material obtained in poultry processing plants after viscera was
removed, but prior to final chilling and further processing. There are conflicting results
regarding whether commercial chilling has any effect on the persistence of antibiotic resistant
Salmonella variants (Mohamed et al., 2014). This could be explained by the fact that Salmonella
invasion depends on multiple host and bacteria factors, one of which is the presence or absence
of genes in the bacterium that encode for various virulence factors, and whether these factors are
expressed in the bacterium before or during the infection (Olah et al., 2005). While some
research has shown that the chilling step may impact the recovery of selected Salmonella clonal
groups, other data found that the chilling step had no effect on antimicrobial susceptibility, as
measured by the presence of class-I integrons, blaCMY genes, and virulence genes including invA,
pagC and spvC (Mohamed et al., 2014). By understanding the impact of that Salmonella genetic
differences have on virulence, targeted interventions can be developed that are effective at
reducing the likelihood of severe infections and maintaining the effectiveness of selected
antimicrobials. Measures of other factors in vivo, such as the production of volatile fatty acids in
the presence of specific Saccharomyces cerevisiae fermentation metabolites, needs further study
to determine the correlation between these measurements and Salmonella virulence and
susceptibility to antibiotics. The potential benefits to animal and human health from
Saccharomyces cerevisiae fermentation metabolites modulating Salmonella virulence and
antimicrobial susceptibility in broiler ceca material have not been clearly quantified, and need
further research.
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TABLES AND FIGURES

Table 1
Ceca Sample Collection Information

1

Sample Cycles

Treatments1

Plants

1

CON

A2

2

SCT

B2

3

C3

4

D3

Treatments: CON = Commercial broilers fed control diet ; SCT = treatment
of commercial birds fed control diet + Saccharomyces cerevisiae metabolites

2

Plants A & B processed products primarily as whole, in-tact, or components

3

Plants C & D processed boneless products and bone-in component parts
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Treatment Cycle

CON
43.96 b

SCT1

SCT2

43.91b
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43.77
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% of hilA Expression Compared to Control (CON) 1
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Figure 1. Broiler Ceca Salmonella Virulence of Flocks of Control (CON) Birds vs.
Flocks Treated with Saccharomyces Cerevisia Yeast Product (SCT)
1 Expression

of hilA measured at the lowest number of PCR replication cycles required to
visualize amplicons under UV light during electrophoresis.
a - b percentages are different at p ≤ 0.05
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Figure 2. Broiler Ceca Salmonella Resistance to Selected Antibiotics
Flocks of Control (CON) vs. Treated with Saccharomyces Cerevisia
Yeast Metabolites (SCT)
* percentages within same antibiotic are different at p ≤ 0.05
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ABSTRACT
Strategies to reduce Salmonella and other enteric pathogens in raw poultry products have
traditionally involved a multi-hurdle approach by poultry producers, processors, and end-users.
Poultry live bird growing operations and processing plants have frequently evaluated the impact
of such interventions by evaluating poultry carcasses and/or plant environmental samples.
Increased emphasis is being placed on understanding the impact that interventions have on the
pathogen loads of specific poultry component parts. The impact of interventions on poultry parts
has become more important to regulators and consumers, as these are very common ways to
market chicken products compared to whole carcasses. In this study, commercial poultry
processing plants provided broiler ceca and carcass portions that had been processed from
chickens administered a commercial diet as control, or the same diet with an additional feed
supplement which included Saccharomyces cerevisiae fermentation metabolites derived from
dried yeast. Ceca and parts provided from chickens administered Saccharomyces cerevisiae
metabolites were compared to the ceca and parts from non-treated chickens, with comparisons
made on the presence and quantity of Salmonella in the ceca and on the component parts
provided after commercial harvest. The ceca and parts obtained from chickens treated with the
Saccharomyces cerevisiae supplement displayed reduced Salmonella presence and quantity
compared to ceca and parts from conventional flocks. These results indicated that broilers fed
supplemental Saccharomyces cerevisiae metabolites may have a reduction in Salmonella
quantities and presence in ceca, which could potentially alter the overall chicken microflora and
lead to reduced Salmonella presence and quantity on component parts.
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INTRODUCTION
In poultry production, pathogen reduction has been an area of continual emphasis for
many years, with increasing needs to find alternative methods to reduce bacteria in a sustainable
manner. The United States Department of Agriculture (USDA) Food Safety Inspection Service
(FSIS) has implemented new pathogen performance standards for various types of raw poultry
products, specifically for the pathogenic organisms Salmonella and Campylobacter (USDA
FSIS, 2015). These standards have been made more stringent over the years, as the government
attempts to achieve goals for reducing foodborne illness under its Healthy People initiatives
(USDHHS ODPHP, 2018). In order to achieve the goals of improving food safety while meeting
the requirements of regulators and consumers, poultry processing managers, researchers and
regulators have focused on multi-hurdle strategies in processing plants by using combinations of
antimicrobial sprays, dips, and rinses to reduce pathogenic and spoilage bacteria (Berrang and
Bailey, 2009; Buncic and Sofos, 2012; Shackelford et al., 1993; USDA FSIS, 2015). Also, the
antimicrobial interventions are most effective when pathogen loads are minimal on incoming
animals and raw materials, prior to processing. Therefore, while antimicrobial interventions
have been proven effective at reducing pathogens and bacterial loads, these interventions cannot
be used exclusively for all applications. Research is very limited in determining how novel
approaches to pathogen reduction in live poultry production impact reductions of bacteria after
product is processed into component parts, packaged and ready for sale to consumers.
Concurrent to the challenges to reduce pathogens, poultry producers have the additional
requirement of meeting increased consumer demand for products with limited exposure to
traditional antimicrobial interventions. Some consumers prefer to purchase products not treated
with antimicrobials to reduce bacteria, due to concerns about chemicals and their impact on
consumer health and/or product organoleptic characteristics. There is also increased demand for
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reducing or eliminating antibiotic use in food animals, so veterinarians have worked to minimize
prescriptions to prevent and/or treat diseases and are replacing them with pathogen-reduction
strategies using novel approaches. The USDA has also increased its oversight of voluntary
product claims for products without antibiotics, such as naturally-raised livestock (USDA, 2009),
and the USDA Agricultural Marketing Service (AMS) certification systems for companies that
have animal production controls routinely audited (USDA AMS, 2018).
Due to the challenges to reduce pathogens in raw poultry while staying cognizant of
consumer interests to reduce antimicrobials and other traditional interventions and antibiotics,
many meat and poultry producers continually seek new technologies and novel interventions that
achieve both requirements. One strategy has been the administration of probiotics and/or
prebiotics to animal feeds or at farms during the growing cycle. Beneficial microbial cultures
have been shown to stimulate the immune system in animals (Gibson and Roberfried, 1995;
Netherwood et al., 1999) and enhance epithelial innate immunity-related gene expression
through anti-inflammatory effects and reduced pro-inflammatory cytokine expression (AmitRomach et al., 2010; Pagnini et al., 2010). Mannon oligosaccharides derived from
Saccharomyces cerevisiae cell walls have been effective alternatives to antibiotics for some
applications in meat animals (Rozeboom et al., 2005; Shen et al., 2009). In poultry,
Saccharomyces cerevisiae and other yeast based products have been successfully used for a
variety of purposes, such as alleviation of lipopolysaccharide-induced inflammation (Wang et al.,
2016), and improved strength and structure of gut physiology (M’Sadeq et al., 2015; Solis de los
Santos et al., 2005).
The purpose of this experiment was to determine the effectiveness of feeding broilers a
commercial supplement with the dried metabolites of Saccharomyces cerevisiae on the presence
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and quantity of Salmonella in broiler chickens in commercial settings, as measured in the ceca
and component parts collected at the time of processing. This study included replicate analyses
from poultry ceca and products collected at the time of harvest from 4 different processing
plants, representing 12 different integrated broiler farms spanning a total of three different states.
The ceca and parts from control, non-treated commercial flocks were evaluated as a baseline, so
that ceca and parts obtained from flocks administered the Saccharomyces cerevisiae metabolites
could be compared over multiple repeated analyses.
MATERIALS AND METHODS
Experimental design
Broiler ceca and parts were provided by commercial processing plants, obtained for
analysis after production, representing samples from broiler parts processed from twelve
integrated commercial farms. The experimental samples were obtained from 4 plants that
obtained samples from 3 representative flocks per plant, located in multiple regions of the United
States with extensive poultry production. Plants and farms were overseen by best management
practices and programs typical in the poultry industry, with oversight by poultry veterinarian
services and production management. Each plant and farm was part of an integrated poultry
complex, and the farms selected all were designed to grow and harvest birds at two basic types of
product mixes for its existing customers. Of the 12 farms, a total of 6 farms were used to process
products at 2 plants that manufactured finished products primarily as whole in-tact components,
including the skeletal bones, muscles, and outer skin layer. Some examples of markets using
these types of component parts included retail groceries, fast food restaurants, and various
foodservice entities who utilized chicken component bone-in parts. The other 6 farms were used
to provide poultry to 2 other plants that manufactured a significant volume of items marketed as
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boneless portions, while still maintaining some sales volume of items that included skeletal bone
material.
The control experimental period included collection of control samples of ceca and
component parts, obtained after each flock was harvested and processed by a commercial
facility. These samples were collected to establish the baseline control for the ceca and portions
in respect to Salmonella presence and quantities within each flock at the time of harvest. The
components collected and analyzed as control were obtained post-harvest from birds that had
been administered a conventional diet, typical of the commercial broiler industry, designed for
standard poultry performance. Prior to processing, the birds were allowed ad libitum access to
feed and water, and feed was withdrawn prior to catching for transport to the commercial
processing plant. Flock density, lighting programs, and temperature were managed per industry
standards and held constant across the flocks in each complex. When the broilers reached their
scheduled harvest dates, the birds were transported from the farm in conventional transport
coops, and then birds were harvested at a commercial poultry processing plant under USDA
inspection. The plant and processing lines were held constant for each flock during the multiple
phases of the experiment. Chickens were processed in one of the 4 commercial plants as
previously described. None of the broiler processing facilities were affiliated with the University
of Arkansas. The birds were grown and processed under commercial management and were
routinely monitored for optimal animal care practices, compliant with the animal welfare
requirements of the National Chicken Council, as certified by the Professional Animal Auditor
Certification Organization (NCC, 2018).
The second experimental period consisted of obtaining ceca and component parts from
commercially-harvested broilers at the same facilities. The samples were from the same plants
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as the control samples from the next subsequent time each of the test flocks was harvested.
During the treatment period, flocks were grown by the same commercial operators under the
same conditions as the control period. At harvest, ceca and component parts were measured for
Salmonella presence and quantity, in a similar manner as the control period. The treatment
flocks were fed the identical commercial poultry diet as the control flock, with 1.25 lb per ton
(0.62 kg / metric ton) of Saccharomyces cerevisiae yeast fermentation metabolite products added
on top of the control formulation. Feeds provided were manufactured at the same commercial
feed mills used for controls, pelleted, and presented ad libitum along with water, lighting, and
other environmental conditions held constant throughout the life of the flocks. Birds were
processed at the same commercial plants, using the same procedures as the control flocks. After
birds were processed in the commercial facilities, the ceca and component parts were provided
by the commercial integrators for analysis. After the second experimental period, a third and
fourth experimental period were also observed, using the same conditions and data collection
protocols as the second experimental period.
Sampling of Broiler Ceca and Component Parts
Samples of ceca and component parts were provided after birds were commercially
processed and harvested. For sampling of ceca, broilers were initially harvested under
management of a commercial facility, who removed viscera from the carcass and produced
component broiler parts using industry procedures and equipment under USDA inspection.
Ceca samples were acquired by manually removing the ceca from viscera samples by stripping it
free of the intestine and pinching at the base at the ceco-colon junction. Aseptic sampling
techniques were conducted using sterile gloves and placing samples into sanitary whirl-pack
specimen bags. Gloves were changed between each sample collected. A total of 25 ceca were
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collected after harvest from each flock, individually packed, and stored under refrigeration
before and during shipment to an offsite laboratory for analysis. The total ceca collected
included 300 samples, evenly divided between each sample period. The cecal sampling schedule
is shown in Table 1.
To collect samples of component parts, the 4 different commercial facilities provided the
parts after birds were harvested, carcasses chilled, and component parts manufactured under
standard procedures. Parts were selected that were representative of high volume sales from the
processing plants. The parts were selected in the normal process flow, but prior to any final parts
sprays or dips with antimicrobial chemicals. In this experiment, half of the plants selected had a
predominant sales mix of whole component parts that consisted of both edible meat tissue and
bones, and the other half of the plants produced a more predominant ratio of boneless products.
The parts samples were collected at the point of packaging, with 4 lb collected for each sample.
For each 4 lb sample, all parts included were the same unique part type. From the plants that
produced products for sale primarily as whole component parts (designated as Parts Group A) ,
the samples collected from each representative flock were evenly distributed with 2 samples of
bone-in split breast quarters, 2 samples of leg quarters, 2 samples of breast tenderloins, 2 samples
of wings, and 2 samples of front half frames. For the plants producing products for sales
primarily as boneless items (designated as Parts Group B), the items collected were evenly
distributed with 2 samples of boneless breast meat, 2 samples of boneless tenderloins, 2 samples
of boneless leg meat, 2 samples of wings, and 2 samples of front half frames. Each sample of
portions collected was rinsed with media using the ratio of 400mL of buffered peptone water for
every 4 lb of portions in the homogenous rinsate solution. The buffered peptone water was
deemed an acceptable rinse media as this was the traditional media used in each facility by
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regulators and industry personnel, and the samples selected were collected prior to final
antimicrobial rinses, thus neutralized media was not required. Each sample of parts with the
buffered peptone water solution was placed into a sterile sampling bag, the bag was held closed,
and the mixture of parts and buffered peptone water were swirled in a gentle rocking motion for
one minute to ensure the surfaces of the cut samples were completely exposed to the sample
rinse media. The homogeneous rinsate was transferred to a sterile specimen cup, with 80ml
collected, sealed in the container, and stored and shipped under refrigeration to an outside
laboratory. A total of 10 samples of parts rinses per flock were collected, for a total of 120
samples during the entire experiment. The parts rinse sampling schedule is shown in Table 1.
Analysis of Salmonella Presence and Quantity in Broiler Ceca and Component Parts.
Samples of ceca and rinsates from parts were shipped to an independent laboratory for
analysis. Each of the ceca were weighed and then aseptically placed in 10mL of Lennox L broth
(Invitrogen, Carlsbad, CA) and manually massaged to release the cecal contents and dislodge
Salmonella colonies from adherence sites. Rinsate samples were diluted at a 1:10 dilution in
Lennox L broth and were also vortexed prior to plating. An aliquot of 100µL of each mixture
was dispersed onto Xylose Lysine Deoxycholate (XLD) agar plates (Fisher Scientific, Pittsburg,
PA) selective for Salmonella (Anderson et al., 2015). The agar plates were incubated overnight
at 37oC. The following day, white colonies with black centers were enumerated and reported
based on a 1:100 dilution factor as CFU/gm of cecal material and CFU/mL of rinsate.
Statistical Analysis
The statistical analysis was completed with SAS JMP® Pro version 13.2.1 (SAS Institute,
2016). For the reporting of colony forming units (CFU’s), the enumerated results were
converted to log10 values, and compared using the Oneway Analysis of Variance and the Tukey-
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Kramer test to determine separation of means. For comparison of percentages, a Contingency
Analysis of Proportions was performed using the Pearson’s Chi-square test, a Likelihood Ratio
analysis, and Fisher’s Exact Test for probabilities of differences across treatments. For all
variables being compared, significant differences were defined as P ≤ 0.05. For selected
variables that are not different using alpha = 0.05 but are different at P ≤ 0.10, the differences at
this alpha level are noted.
RESULTS AND DISCUSSION
The results of the reduction in Salmonella attributable to the Saccharomyces cerevisiae
metabolite are shown in Figures 1 – 4. The treatment of broilers with the dried metabolites of
Saccharomyces cerevisiae resulted in significant reductions in the presence and quantity of
Salmonella in broiler ceca and component parts in the initial and subsequent test cycles after
baselines were established from samples collected of untreated broilers.
Figures 1 and 2 show the reduction of enumerated Salmonella log10 quantity and overall
Salmonella percent prevalence in the ceca, respectively. Because the ceca is an established
indicator of the impact of live bird interventions on Salmonella presence, and is a portion of the
broiler anatomy that has been repeatedly studied due to its ability to enhance pathogen durability
and growth, the ceca pathogen results in this study may be considered a realiable indicator of the
effectiveness of the Saccharomyces cerevisiae metabolite on Salmonella reduction. The
reduction of Salmonella log10 counts in the ceca during each period of treatment with
Saccharomyces cerevisiae supplement was significant (P < 0.05) during each treatment cycle as
compared to the control period. In the Group A plants producing primarily whole bone-in
portions, the overall reduction in Salmonella counts was 0.21 log10 during period TRT1,
increasing to 0.30 log10 MPN during TRT2, and stabilizing at 0.27 log10 MPN during the TRT3
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treatment period. In a similar manner, the Group B plants had an overall reduction of Salmonella
counts compared to the control of 0.20 log10 during period TRT1, increasing to 0.27 log10 MPN
during TRT2, and 0.24 log10 MPN during the TRT3 treatment period. In like manner, the
percent prevalence of Salmonella was significantly lower in the ceca in all TRT periods as
compared to the CON period (Figure 2).
The reduction in the quantities and prevalence of Salmonella in the ceca after the
implementation of the yeast-based Saccharomyces cerevisiae treatment was consistent with
findings from other research. Yeast fermentation metabolites reduced Salmonella typhimurium
in a culture derived from chicken ceca mixed with feed (Rubinelli et al., 2016). Other studies
have shown that birds fed a Saccharomyces cerevisiae supplement demonstrated had decreased
prevalence of the pathogen in the ceca, cloaca, and carcass skin (Mountzouris et al., 2015). The
mechanism of decreased quantity and prevalence of Salmonella in the ceca may be explained by
multiple factors. For example, treatments with Saccharomyces cerevisiae have been shown to
increase the presence of goblet cells which form a mucous blanket in the intestine, leading to the
formation of a large surface area for Salmonella adhesion (Baurhoo et al., 2007; Chee et al.,
2010; Chichlowski et al., 2007; Leforesteier et al., 2009). This treatment can also form a
physical protective barrier for the epithelium in the cecal tonsil, causing a reduction of bacterial
attachment to cecal tonsil tissues (Brufau et al., 2015), through biochemical reactions of
pathogens with lectins in the mucous blanket and/or through low affinity bonds (Barnett et al.,
2012). A reason for the reduction in ceca Salmonella may be improved overall gut health, as
demonstrated by increased villus length or height in the ileum (Solis de los Santos et al., 2005;
Morales-López et al., 2009) and duodenum (Rodriquez-Lecompte et al., 2012). Contributing
factors causing the decrease in ceca Salmonella may be explained by early reduction of
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Salmonella in the gastro-intestinal tract, consistent with findings that broilers inoculated with
various Salmonella serotypes, such as Salmonella typhimurium or Salmonella Dublin, at age 3
days had significantly less presence of either Salmonella serotype in the ceca at day 10 (Spring et
al., 2000).
In addition to the reduction of Salmonella in the ceca, the component parts showed a
similar reduction in both Salmonella MPN counts and prevalence (Figures 3 and 4, respectively).
For Parts Group A, this reduction included a consistent reduction in MPN log10 counts of 0.25,
0.26, and 0.25 in the treatment periods TRT1, TRT2, and TRT3, respectively, whereas the
reduction of MPN log10 counts in Parts Group B was even greater at 0.51, 0.51, and 0.50 during
the TRT1, TRT2, and TRT3 periods, respectively. The average reduction of Salmonella
incidence rates was 12.4% across all groups and treatment periods. These research results were
similar to findings from a comparison of competitive exclusion and probiotic culture products in
broilers, including a chicken-origin competitive exclusion product, a Saccharomyces cerevisiae
probiotic culture, and a probiotic Pediococcus acidilactici culture, which all reduced the
Salmonella percentage in litter, ceca, and carcasses, in both summer and winter tests (Al-Zenki et
al., 2009).
The fact that both ceca and component parts showed consistent and predictable reduction
of Salmonella suggests the Saccharomyces cerevisiae metabolite compound had a beneficial
effect on the general microbiome of the internal systemic physiology of the chickens, with the
overall lower incidence of the pathogen in the gastrointestinal tract contributing to lower
presence and quantity on the component parts. Inclusion of products in the diet made from
Saccharomyces cerevisiae metabolites appear to allow for the entire microbiome in the ceca to
stabilize at an earlier age in broilers than those in normal diets (Park et al., 2017). Studies have
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revealed that birds fed diets supplemented with Saccharomyces cerevisiae maintained decreased
Salmonella at ages 16, 28, and 42 days (Roto et al., 2017). A mature and stable gut microbiome
has been suggested as an effector of pathogen control, reduced mortality, improved growth
performance, and overall health of the host (Patterson, 2012). All of these factors support the
findings from the present study, suggesting that the use of the Saccharomyces cerevisiae
metabolite supplement resulted in systemic reduction of Salmonella prevalence and quantity, as
measured in the ceca and component parts over repeated trial periods.
In summary, the administration of Saccharomyces cerevisiae metabolites has been shown
to be an effective alternative to reduce the presence and quantity of Salmonella in broiler ceca
and broiler parts, including whole component bone-in products and a mixture of boneless and
bone-in portions. Poultry integrators evaluating options to reduce pathogens in a multi-hurdle
approach may choose to use the metabolites of Saccharomyces cerevisiae as an intervention
option to alleviate some of the other interventions required to achieve regulatory standards while
maintaining customer requirements. The effectiveness of Saccharomyces cerevisiae metabolites
in reducing Salmonella in broilers may be the result of multiple physiological mechanisms, such
as increased intestinal villus length or height, and the creation of a mucous blanket over parts of
the intestine which prevents Salmonella adherence to epithelial cells.
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TABLES AND FIGURES

Table 1
Sample Sizes of Broiler Ceca and Component Parts Rinses for Comparison of
Salmonella Prevalence and Quantification in Control (CON) Broilers to
Broilers Treated with Saccharomyces Cerevisia Yeast Metabolite (TRT)

Treatment Periods1

CON

TRT1

TRT2

TRT3

TOTAL

Ceca2

300

300

300

275

1,175

Parts Rinses 3

120

120

120

120

480

Total

420

420

420

420

1,655

1

Treatment periods included CON (control, no supplement), TRT1 (first cycle of treated
broilers after control period), TRT2 (second cycle of treated broilers), and TRT3 (third cycle
of treated broilers).

2

Broiler ceca samples consisted of 25 per sample group

3

Broiler parts rinsate samples were conducted using buffered peptone water rinse of 4 lbs.
samples, with duplicate rinse samples for each part type. For plants producing primarily
whole in-tact parts, rinses were taken of bone-in breasts, bone-in leg quarters, tenderloins,
wings, and frames, for a total of 10 parts rinses from each test group. For plants producing
primarily boneless meats, rinses were taken of boneless breast meat, boneless leg meat,
tenderloins, wings, and frames, for a total of 10 parts rinses for each test group. Total parts
rinse samples consisted of 10 rinses per sample group, 12 replicates per treatment.
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Figure 1. Salmonella Log10 Counts per Gram in Broiler Ceca from Control
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1
Yeast Metabolite (TRT)
Treatmentcycles
cycleswere
wereanalyzed
analyzed
from
ceca
collected
the same
after over
Treatment
from
ceca
collected
fromfrom
the same
flocksflocks
after harvest
harvest
over
sequential
treatment
periods
including
non-supplemented
control
flocks
sequential treatment periods including non-supplemented control flocks (CON), treated
flocks
(CON),
treatedtreated
flocksflocks
cyclecycle
1 (TRT1),
treated
flocks flocks
cycle cycle
2 (TRT2),
and treated flocks
cycle 1 (TRT1),
2 (TRT2),
and treated
3 (TRT3).
cycle 3 (TRT3).

11

Group A samples were collected from plants that manufactured primarily whole part

components
and cut-up
with
theplants
bones that
included
in the majority
of products
Group
A samples
wereportions
collected
from
manufactured
primarily
wholesold.
part
components and cut-up portions with the bones included in the majority of products
Group B samples were collected from plants that manufactured a significant volume of breast
sold.

meat and leg meat items, with the bones removed from a significant volume of products sold.

Group B samples were collected from plants that manufactured a significant volume of
a–b
Means
withinitems,
wholewith
partsthe
products
different
letters volume
are different
breast
meatcompared
and leg meat
bones program
removedwith
from
a significant
of
at P ≤ 0.10sold.
products
a – bMeans
y–z

compared within boneless meat products program with different letters are

Means compared within whole parts products program with different letters are
different at P ≤ 0
different at P ≤ 0.10

y–z

Means compared within boneless meat products program with different letters are
different at P ≤ 0.05
134

25%

Salmonella Percent Positve

20%

20.00%

a
y

Group A

Group B

18.00%

15%
b

z
10.67%
10.00%

10%

b
b

6.00%

z

8.00% 8.00%

z

4.67%

5%
0%
CON

TRT1
TRT2
Treatment Cycle

TRT3

Figure 2. Percent Salmonella Prevalence in Broiler Ceca from Control Samples
(CON) and in Ceca from Broilers Treated with Saccharomyces Cerevisia Yeast
Metabolite (TRT)1
1

Treatment cycles were analyzed from ceca collected from the same flocks after
harvest over sequential treatment periods including non-supplemented control flocks
(CON), treated flocks cycle 1 (TRT1), treated flocks cycle 2 (TRT2), and treated flocks
cycle 3 (TRT3).
Group A samples were collected from plants that manufactured primarily whole part
components and cut-up portions with the bones included in the majority of products
sold.
Group B samples were collected from plants that manufactured a significant volume of
breast meat and leg meat items, with the bones removed from a significant volume of
products sold.
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Means compared within whole parts products program with different letters are
different at P ≤ 0.05
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Means compared within boneless meat products program with different letters are
different at P ≤ 0.05
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Figure 3. Salmonella Log10 Counts per ml Rinsate on Broiler Component Parts
from Control Samples (CON) and on Parts from Broilers Treated with
Saccharomyces Cerevisia Yeast Metabolite (TRT)1
1

Treatment cycles were analyzed from portions collected from the same flocks over
sequential treatment periods including non-supplemented control flocks (CON), treated
flocks cycle 1 (TRT1), treated flocks cycle 2 (TRT2), and treated flocks cycle 3
(TRT3).
Parts Group A consisted of equivalent samples of bone-in split breast quarters, bone-in
leg quarters, tenderloins, wings, and front half frames. Samples collected in process
prior to final antimicrobial interventions.
Parts Group B consisted of equivalent samples of boneless breast meat, boneless leg
meat, tenderloins, wings, and front half frames. Samples collected in process prior to
final antimicrobial interventions.

a–b

Means compared within whole parts products program with different letters are
different at P ≤ 0.05
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Figure 4. Percent Salmonella Prevalence on Broiler Portions from Control
Samples (CON) and on Portions from Broilers Treated with Saccharomyces
Cerevisia Yeast Metabolite (TRT)1
1

Treatment cycles were analyzed from portions collected from the same flocks over
sequential treatment periods including non-supplemented control flocks (CON), treated
flocks cycle 1 (TRT1), treated flocks cycle 2 (TRT2), and treated flocks cycle 3
(TRT3).
Portions selected were 50% from Group A plants, and 50% from Group B Plants.
Portions from Group A plants consisted of equivalent samples of bone-in split breast
quarters, bone-in leg quarters, tenderloins, wings, and front half frames. Portions
selected from Group B plants consisted of equivalent samples of boneless breast meat,
boneless leg meat, tenderloins, wings, and front half frames. Portion samples were
collected in process prior to final antimicrobial interventions.
a–b

Means compared within whole parts products program with different letters are
different at P ≤ 0.05
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CONCLUSIONS
Researchers and integrated poultry companies have a common goal of finding novel new
technologies to optimize bird performance while reducing bacteria relevant to food safety and
bird health. Food safety, broiler performance, and yield efficiency are inter-connected goals; in
this research, those variables were analyzed in respect to a yeast-based supplement that included
Saccharomyces cerevisiae fermentation metabolites. This research was conducted to determine
if this technology could be considered a viable option to consider in the continual search for
effective strategies in broiler operations to optimize bird performance and yields, while
contributing to pathogen reduction in support of other multi-hurdle food safety interventions.
In this dissertation research, the Saccharomyces cerevisiae metabolite intervention was
studied to understand its impact on Salmonella in the broiler ceca and on component parts. This
was a novel research project, as most previous studies of this beneficial micro-organism in
broilers have focused on analyzing only internal organs. With growing consumer demand for
portioned parts of raw muscle proteins, and tightening regulations regarding pathogens on those
parts, the need for understanding the impact of any intervention on edible portions is appropriate.
The results from this research indicated that a Saccharomyces cerevisiae fermentation metabolite
product can have beneficial effects in reducing Salmonella in broiler ceca and component
portions of the carcass. As previously discussed, the mechanisms of action of some yeast-based
products can be the results of several factors. Although not analyzed in this study, such products
have been shown to work through improved gut morphology with longer and deeper villi at the
brush border (Rodriquez-Lecompte et al., 2012), creation of a protective mucous layer that
restricts gut colonization in the intestinal tract (Baurhoo et al., 2007; Chee et al, 2010), and
agglutination of pathogenic bacteria to dried yeast (Kogan and Kocher, 2007; White et al., 2002).
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One benefit of using the Saccharomyces cerevisiae fermentation metabolite functional
ingredient technology is that reduced pathogen colonization in the live bird may allow
commercial processing plants to streamline or reduce the use of antimicrobials and other
interventions during broiler processing. This could serve the dual purpose of offsetting costs of
in-plant interventions, while meeting growing consumer interests to purchase chicken that has
been exposed to fewer compounds during production that may be required to reduce pathogens
and achieve tightening regulatory requirements.
Another part of this research included a study using tightly-controlled pens of broilers not
exposed to typical industry challenges. This study resulted in similar bird performance and
yields in treated and non-treated birds. Since the birds studied in the research pens were not
subject to typical physiological challenges and stressors, the benefits of the Saccharomyces
cerevisiae metabolite functional ingredient may have been minimized compared to expected
impacts in commercial settings, consistent with expectations suggested by other researchers
(Hahn-Didde and Purdum, 2016). As noted previously, other researchers have shown
improvements in broiler performance using Saccharomyces cerevisiae metabolite treatments or
other similar compounds, leading to improved broiler production (Bovo et al., 2015; Kidd et al.,
2013). Improvements in live animal performance and production have also been observed in
other food animal species exposed to products with Saccharomyces cerevisiae based compounds
or metabolites (Gerritsen et al, 2012; Mao et al., 2013). As previously reviewed, these may have
been due to the conserved intestinal structures that were improved across multiple species with
similar mechanisms of action realized from various functional ingredients. When used in a
commercial setting, companies electing to use a Saccharomyces cerevisiae metabolite product
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would gain important information by measuring its impacts on pathogen quantities, feed
conversion, yields, bird health, and reduction in the use of in-plant antimicrobials.
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APPENDIX

The Institutional Animal Care and Use Committee (IACUC) approval cited in Chapter 3
of this dissertation referred to University of Arkansas IACUC approved protocol #17065: The
Effect of XPC on broiler performance, April 7, 2017. Data collected in this study was obtained
by approved research staff and reported to the dissertation author and committee for analysis.
No other IACUC protocols were required for any other chapters, all consisting of data provided
by commercial operations.
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